UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from            to            .

 

Commission File Number 001-41321

 

PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

Cayman Islands   N/A
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification Number)

 

18 Forum Lane, 3rd floor,

Camana Bay, PO Box 757, Grand Cayman, KY1-9006

(Address of principal executive offices)

 

+1 345 640 4900
Registrant’s Telephone Number, Including Area Code

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which
Registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant   PLAOU   The Nasdaq Stock Market LLC
Class A ordinary shares, included as part of the units   PLAO   The Nasdaq Stock Market LLC
Redeemable warrants, included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   PLAOW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ☐

 

As of November 13, 2023,  there were 16,880,481 Class A ordinary shares, par value $0.0001 per share and 5,750,000 Class B ordinary shares, par value $0.0001 per share, issued and outstanding, respectively.

 

 

 

 

 

 

PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.

 

table of contents

 

    Page
PART I – FINANCIAL INFORMATION 1
     
Item 1. Condensed Financial Statements (Unaudited) 1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
Item 3. Quantitative and Qualitative Disclosures About Market Risk 27
Item 4. Controls and Procedures 27
     
PART II - OTHER INFORMATION 28
     
Item 1. Legal Proceedings 28
Item 1A. Risk Factors 28
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
Item 3. Defaults Upon Senior Securities 28
Item 4. Mine Safety Disclosures 28
Item 5. Other Information 28
Item 6. Exhibits 29

 

i

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Condensed Financial Statements

 

  Page
Condensed Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022 2
   
Unaudited Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022 3
   
Unaudited Condensed Statements of Changes in Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2023 and 2022 4
   
Unaudited Condensed Statements of Cash Flows for the Three and Nine Months Ended September 30, 2023 and 2022 5
   
Notes to Condensed Financial Statements 6

 

1

 

 

PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP
CONDENSED BALANCE SHEETS

 

   September 30,
2023 (Unaudited)
   December 31,
2022
 
         
ASSETS        
Cash  $182,243   $707,749 
Prepaid expenses   133,855    307,756 
Marketable securities held in Trust Account   183,950,121    240,311,986 
Total current assets   184,266,219    241,327,491 
Total Assets  $184,266,219   $241,327,491 
           
LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable  $226,158   $
 
Due to related party   1,200,000    3,144 
Accrued expenses   74,757    68,627 
Derivative warrant liabilities   1,560,000    2,340,000 
Deferred underwriting fees payable   8,050,000    8,050,000 
Total current liabilities   11,110,915    10,461,771 
Total liabilities   11,110,915    10,461,771 
           
Commitments and Contingencies (Note 6)   
 
    
 
 
Class A ordinary shares subject to possible redemption, $0.0001 par value; 16,880,481 and 23,000,000 shares at $10.90 and 10.45 per share at September 30, 2023 and December 31, 2022, respectively   183,950,121    240,311,986 
Shareholders’ deficit          
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding   
    
 
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none issued or outstanding (excluding 16,880,481 and 23,000,000 shares subject to possible redemption at September 30, 2023 and December 31, 2022, respectively)   
    
 
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding   575    575 
Additional paid-in capital   
    
 
Accumulated deficit   (10,795,392)   (9,446,841)
Total shareholders’ deficit   (10,794,817)   (9,446,266)
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit  $184,266,219   $241,327,491 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

2

 

 

PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)

 

   For the   For the   For the   For the 
   Three Months
Ended
   Three Months
Ended
   Nine Months
Ended
   Nine Months
Ended
 
   September 30,
2023
   September 30,
2022
   September 30,
2023
   September 30,
2022
 
General and administrative expenses  $241,063   $240,538   $928,551   $728,577 
Loss from operations   (241,063)   (240,538)   (928,551)   (728,577)
Change in fair value of derivative warrant liabilities   (353,600)   (1,300,000)   780,000    4,720,500 
Realized gain on investments held in Trust Account   2,360,877    1,101,855    7,601,882    1,403,465 
Transaction costs allocated to derivative warrant liabilities   
    
    
    (314,508)
Net income  $1,766,214   $(438,683)  $7,453,331   $5,080,880 
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted
   16,880,481    23,000,000    20,511,844    16,934,066 
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption
  $0.13   $(0.01)  $0.38   $0.65 
Weighted average shares outstanding of Class B non-redeemable ordinary shares, basic and diluted
   5,750,000    5,750,000    5,750,000    5,552,198 
Basic and diluted net income (loss) per share, Class B non-redeemable ordinary shares
  $(0.07)  $(0.05)  $(0.05)  $(1.06)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3

 

 

PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP
CONDENSED STATEMENTS OF CHANGES IN ORDINARY SHARES SUBJECT TO POSSIBLE
REDEMPTION AND SHAREHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023
(Unaudited)

 

   Ordinary Shares Subject
to Possible Redemption
   Ordinary Shares   Additional       Total 
   Class A   Class B   Paid-In   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance as of January 1, 2023   23,000,000   $240,311,986    5,750,000    575   $
            -
   $(9,446,841)  $(9,446,266)
Accretion of Class A ordinary shares to redemption value   -    2,569,175    -    
-
    
-
    (2,569,175)   (2,569,175)
Net income   -    
-
    -    
-
    
-
    2,278,938    2,278,938 
Balance as of March 31, 2023 (unaudited)   23,000,000   $242,881,161    5,750,000   $575   $
-
   $(9,737,078)  $(9,736,503)
                                    
Redemption of Class A ordinary shares   (6,119,519)   (65,163,747)   
-
    
-
    
-
    
-
    
-
 
Accretion of Class A ordinary shares to redemption value   -    2,971,830    -    
-
    
-
    (2,971,830)   (2,971,830)
Net income   -    
-
    -    
-
    
-
    3,408,179    3,408,179 
Balance as of June 30, 2023 (unaudited)   16,880,481   $180,689,244    5,750,000   $575   $
-
   $(9,300,729)  $(9,300,154)
                                    
Accretion of Class A ordinary shares to redemption value   -    3,260,877    -    -    -    (3,260,877)   (3,260,877)
Net income   -    -    -    -    -    1,766,214    1,766,214 
Balance as of September 30, 2023 (unaudited)   16,880,481   $183,950,121    5,750,000   $575   $-   $(10,795,392)  $(10,794,817)

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022

 

   Ordinary Shares Subject to Possible Redemption   Ordinary Shares   Additional       Total 
   Class A   Class B   Paid-In   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance as of January 1, 2022   
-
   $
-
    5,750,000    575   $24,425   $(49,868)  $(24,868)
Proceeds from the sale of Class A Units   23,000,000    230,000,000    
-
    
-
    
-
    
-
    
-
 
Paid underwriters fees   -    (4,600,000)   -    
-
    
-
    
-
    
-
 
Deferred underwriting fees payable   -    (8,050,000)   -    
-
    
-
    
-
    
-
 
Liability-classified equity instruments - Public Warrants   -    (4,151,500)   -    -    -    -    - 
Other offering costs   -    (815,157)   -    
-
    
-
    
-
    - 
Excess cash received over fair value of Private Placement Warrants   -    
-
    -    
-
    9,251,000    
-
    9,251,000 
Accretion of Class A ordinary shares to redemption value   -    24,483,533    -    
-
    (9,275,425)   (15,208,108)   (24,483,533)
Net loss   -    
-
    -    
-
    
-
    (829,640)   (829,640)
Balance as of March 31, 2022 (unaudited)   23,000,000   $236,866,876    5,750,000   $575   $
-
   $(16,087,616)  $(16,087,041)
                                    
Accretion of Class A ordinary shares to redemption value   -    334,734    -    
-
    
-
    (334,734)   (334,734)
Net income   -    
-
    -    
-
    
-
    6,349,203    6,349,203 
Balance as of June 30, 2022 (unaudited)   23,000,000   $237,201,610    5,750,000   $575   $
-
   $(10,073,147)  $(10,072,572)
                                    
Accretion of Class A ordinary shares to redemption value   -    1,101,855    -    -    -    (1,101,855)   (1,101,855)
Net loss   -    -    -    -    -    (438,683)   (438,683)
Balance as of September 30, 2022 (unaudited)   23,000,000   $238,303,465    5,750,000   $575   $-   $(11,613,685)  $(11,613,110

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4

 

 

PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP
CONDENSED STATEMENTS OF CASH FLOWS
  

(Unaudited)

 

   FOR THE NINE
MONTHS ENDED
SEPTEMBER 30,
2023
   FOR THE NINE
MONTHS ENDED
SEPTEMBER 30,
2022
 
Cash Flows from Operating Activities        
Net income  $7,453,331   $5,080,880 
Adjustments to reconcile net income to net cash used in operating activities:          
Realized gain on investments held in Trust Account   (7,601,882)   (1,403,465)
Transaction costs allocated to derivative warrant liabilities   
-
    314,508 
Change in fair value of derivative warrant liabilities   (780,000)   (4,720,500)
Changes in operating assets and liabilities:          
Prepaid expenses   173,901    (373,145)
Accounts payable   226,158    
-
 
Accrued expenses   6,130    44,281 
Net cash used in operating activities   (522,362)   (1,057,441)
Cash Flows from Investing Activities          
Investment of cash into Trust Account   
-
    (236,900,000)
Proceeds from redemption of marketable securities held in Trust account   65,163,747    
-
 
Purchase of U.S. government treasury obligations   (672,783,585)   (475,200,000)
Trust Account Withdrawal - tax payment        
-
 
Proceeds from redemption of U.S. government treasury obligations   671,583,585    475,200,000 
Purchase of U.S. government treasury obligations   
-
    
 
 
Net cash provided by (used in) investing activities   63,963,747    (236,900,000)
Cash Flows from Financing Activities          
Redemption of Class A ordinary shares subject to possible redemption   (65,163,747)   
-
 
Proceeds from note payable and advances from related party   1,200,000    
-
 
Repayment of note payable   (3,144)   (437,507)
Repayment of amount due to related party   
-
    (147,190)
Proceeds from sale of Class A ordinary shares, gross subject to possible redemption   
-
    230,000,000 
Proceeds from sale of Private Placement Warrants   
-
    14,500,000 
Offering costs paid   
-
    (5,151,744)
Net cash used in (provided by) financing activities   (63,966,891)   238,763,559 
           
Net (decrease) increase in cash   (525,506)   806,118 
Cash - beginning of period   707,749    440 
Cash - end of period  $182,243   $806,558 
           
Supplemental disclosure of noncash investing and financing activities:          
Initial class A shares subject to possible redemption  $
-
   $212,383,343 
Accretion of Class A shares to redemption value  $8,801,882   $25,920,122 
Offering costs included in accrued expenses  $
-
   $211,141 
Offering costs paid through promissory note - related party  $
-
   $150,333 
Deferred underwriting fees payable  $
-
   $8,050,000 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

5

 

 

PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

 

Note 1 – Description of Organization, Business Operations, Liquidity and Going Concern Considerations

 

Patria Latin American Opportunity Acquisition Corp. (the “Company”) is a blank check company incorporated in Cayman Islands on February 25, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, ordinary shares purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

As of September 30, 2023, the Company had not commenced any operations. All activities for the period from February 25, 2021 (inception), through September 30, 2023, relates to the Company’s formation, and the initial public offering (“IPO”) described below, and post-IPO expenses. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of realized and unrealized gains on investments from the proceeds derived from the IPO.

 

On March 14, 2022, the Company consummated its IPO of 23,000,000 units (the “Units”), including the issuance of 3,000,000 Units as a result of the underwriter’s exercise in full of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one redeemable warrant of the Company (each whole warrant, a “Public Warrant”), with each Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.

 

The Company’s sponsor is Patria SPAC LLC, a Cayman Islands exempted limited partnership (the “Sponsor”). Simultaneously with the closing of the IPO and pursuant to the private placement warrants purchase agreement, the Company completed the private sale of 14,500,000 warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $14,500,000.

 

Transaction costs amounted to $13,779,665, including $8,050,000 in deferred underwriting fees payable, $4,600,000 in underwriting fees paid and $1,129,665 in other offering costs, of which $314,508 were expensed and $13,456,157 charged to temporary equity.

 

Following the closing of the IPO on March 14, 2022, an amount of $236,900,000 ($10.30 per Unit) of the proceeds from the IPO and the sale of the Private Placement Warrants, comprised of $225,400,000 of the proceeds from the IPO (which is net of $4,600,000 of the underwriter’s fees) and $11,500,000 of the proceeds of the sale of Private Placement Warrants, was placed in a U.S.-based trust account (the “Trust Account”) at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee. The funds in the Trust Account were invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to earnings on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account until the earliest of: (i) the completion of the Initial Business Combination; (ii) the redemption of the Class A Ordinary Shares included in the Units (the “Public Shares”) if the Company is unable to complete the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus); or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the Initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus) or (B) with respect to any other material provisions relating to shareholders’ rights or pre-Initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses.

 

6

 

 

On June 12, 2023, the Company held an extraordinary general meeting of the Company’s shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved amendments to the Company’s Amended and Restated Memorandum and Articles of Association to extend the date (the “Termination Date”) by which the Company has to consummate an initial business combination from June 14, 2023 (the “Original Termination Date”) to June 14, 2024 (the “Articles Extension Date”), in addition to other proposals. Accordingly, the Company now has up to June 14, 2024 to consummate its initial business combination. In connection with the Extraordinary General Meeting, shareholders holding an aggregate of 6,119,519 of the Company’s Class A ordinary shares exercised their right to redeem their shares on June 14, 2023. Following such redemptions, 16,880,481 ordinary shares remained outstanding and subject to redemption. The Trust Account has a remainder balance of $180 million following the withdrawal for Class A ordinary shares redemption. The Company also deposited into the Trust Account an aggregate of $300,000 in order to effect the extension of the termination date for an additional one-month period, from June 14, 2023 to July 14, 2023. The purpose of the extension is to provide time for the Company to complete a business combination. The Company made additional deposits of $300,000 into the Trust account on July 12, 2023, August 12, 2023, and September 13, 2023, in connection with extensions from July 14, 2023 through October 14, 2023. The Company will continue to deposit $300,000 into the Trust Account each month until the earlier of the completion of a Business Combination or liquidation date. On October 10, 2023, the Company made additional deposit of $300,000 representing extension payment through November 14, 2023. On November 13, 2023, the Company made additional deposit of $300,000 representing extension payment through December 14, 2023.

 

Initial Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commission held in Trust and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company only intends to complete a Business Combination if the post-business combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the IPO, management has agreed that an amount equal to at least $10.30 per Unit sold in the IPO, including the proceeds from the sale of the Private Placement Warrants, was held in a Trust Account located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company provides the holders (the “Public Shareholders”) of the Company’s issued and outstanding Class A Ordinary Shares, par value $0.0001 per share, sold in the IPO (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Public Shares for a pro rata portion of the amount then held in the Trust Account. The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. If the Company seeks shareholder approval, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Articles of Association (the “Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below) and any Public Shares purchased during or after the IPO in favor of a Business Combination. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

 

7

 

 

The Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The holders of the Founder Shares (the “initial shareholders”) have agreed not to propose an amendment to the Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

 

If the Company is unable to complete a Business Combination by 27 months after the closing of our IPO on March 14, 2022 of the IPO (the “Combination Period”) and the Company’s shareholders have not amended the Articles of Association to extend such Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman law to provide for claims of creditors and the requirements of other applicable law.

 

The initial shareholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares after the IPO, they will be entitled to liquidating distributions from the Trust if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.30. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.30 per unit or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

8

 

 

Liquidity and Going Concern Consideration

 

As of September 30, 2023, the Company had working capital of $173,155,304. Of the net proceeds from the IPO and associated sale of Private Placement Warrants, $236,900,000 of cash was placed in the Trust Account. The working capital surplus includes the amount of restricted marketable securities held in the Trust Account, deferred underwriting fees payable and derivative warrant liabilities, all of which have been classified as current at September 30, 2023 as a result of the Company being less than 12 months away from consuming the assets held in the Trust Account to either consummate a business combination or to liquidate. Working capital would be $(1,184,817) if the line items described above were not included in the working capital calculation. Cash of $182,243 was held outside of the Trust Account and is available for the Company’s working capital purposes as of September 30, 2023.

 

The Company anticipates that the cash held outside of the Trust Account as of September 30, 2023 will not be sufficient to allow the Company to operate for at least the next 12 months from the issuance of this unaudited condensed financial statements, assuming that a Business Combination is not consummated during that time. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued. Management plans to address this uncertainty through the Business Combination as discussed above. In addition, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required under the Working Capital Loans. There is no assurance that the Company’s plans to consummate the Business Combination will be successful or successful within the Combination Period or that the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors will loan the Company funds as may be required under the Working Capital Loans.

 

These unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Risks and Uncertainties

 

Global economic conditions have been worsening, with disruptions to, and volatility in, the credit and financial markets and rising inflation and interest rates in the U.S. If these conditions persist and deepen, the Company could experience an inability to access additional capital, or our liquidity could otherwise be impacted. Management continues to evaluate the impact related to rising interest rates and current market condition and has concluded while it is reasonably possible that these factors could have a negative effect on the Company’s financial position and results of its operations, the specific impact is not readily determinable as of the date of the unaudited condensed financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

The credit and financial markets have experienced extreme volatility and disruptions due to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia, which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our ordinary shares to be adversely affected.

 

9

 

 

Note 2 – Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the periods presented.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of this unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

10

 

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $182,243 and $707,749 in cash outside of the funds held in the Trust Account, as of September 30, 2023 and December 31, 2022, respectively. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.

 

Investments Held in Trust Account

 

The assets held in the Trust Account were held in U.S. government treasury obligations with maturities of 185 days or less, which were invested in U.S. Treasury securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these securities is included in realized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations.

 

Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Accounting Standards Codification (“ASC”) 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet. The Company’s derivative financial instruments are accounted for as liabilities, and the derivative instrument is recorded at its fair value on the issuance date and is then re-valued at each reporting date. The fair value of the Company’s derivative financial instruments is evaluated at the end of each reporting period, with changes in the fair value reported in the unaudited condensed statements of operations. The Company had no other financial assets or liabilities that were required to be measured at fair value on a recurring basis.

 

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

 

Level 2 – Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets of liabilities, that are observable, or (iv) inputs that are derived principally from or corroborated by market data through correlation or other means.

 

Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

Net Income (Loss) per Ordinary Share

 

The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary share outstanding during the period. The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. For the three and nine months ended September 30, 2023, the Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placements to purchase Class A Ordinary Shares in the calculation of diluted income (loss) per share, since their inclusion is contingent on a future event. For the three and nine months ended September 30, 2022 their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

 

11

 

 

A reconciliation of the income (loss) per share is below:

 

   For The Three
Months
Ended
September 30,
2023
   For The Three
Months
Ended
September 30,
2022
 
Net income (loss)  $1,766,214   $(438,683)
Accretion of temporary equity in excess of fair value   (3,260,877)   (1,101,855)
Net income (loss) including accretion of temporary equity in excess of fair value  $(1,494,663)  $(1,540,538)

 

   For The Nine
Months
Ended
September 30,
2023
   For The Nine
Months
Ended
September 30,
2022
 
Net income (loss)  $7,453,331   $5,080,880 
Accretion of temporary equity in excess of fair value   (8,801,882)   (25,920,122)
Net income (loss) including accretion of temporary equity in excess of fair value  $(1,348,551)  $(20,839,242)

 

The Company’s unaudited condensed statements of operations include a presentation of income (loss) per share for shares of ordinary shares subject to possible redemption in a manner similar to the two-class method of earnings per share. With respect to the accretion of the Class A Ordinary Shares subject to possible redemption and consistent with ASC 480, “Distinguishing Liabilities from Equity,” in accordance with ASC 480-10-S99-3A, the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net income (loss) per ordinary share.

 

   For The Three Months Ended
September 30, 2023
   For The Three Months Ended
September 30, 2022
 
   Class A - Temporary Equity   Class B   Class A - Temporary Equity   Class B 
Basic and diluted net income (loss) per share                
Numerator                
Allocation of net income (loss) including accretion of temporary equity in excess of fair value  $(1,114,896)  $(379,767)  $(1,232,430)  $(308,108)
Deemed dividend for accretion of temporary equity in excess of fair value   3,260,877    
-
    1,101,855    
-
 
Allocation of net income and deemed dividend  $2,145,981   $(379,767)  $(130,575)  $(308,108)
Denominator                    
Weighted average shares outstanding, basic and diluted
   16,880,481    5,750,000    23,000,000    5,750,000 
                     
Basic and diluted net income (loss) per share
  $0.13   $(0.07)  $(0.01)  $(0.05)

 

   For The Nine Months Ended
September 30, 2023
   For The Nine Months Ended
September 30, 2022
 
   Class A - Temporary Equity   Class B   Class A - Temporary Equity   Class B 
Basic and diluted net income (loss) per share                
Numerator                
Allocation of net income (loss) including accretion of temporary equity in excess of fair value  $(1,053,287)  $(295,264)  $(14,953,478)  $(5,885,764)
Deemed dividend for accretion of temporary equity in excess of fair value   8,801,882    
-
    25,920,122    
-
 
Allocation of net income and deemed dividend  $7,748,595   $(295,264)  $10,966,644   $(5,885,764)
Denominator                    
Weighted average shares outstanding, basic and diluted
   20,511,844    5,750,000    16,934,066    5,552,198 
                     
Basic and diluted net income (loss) per share
  $0.38   $(0.05)  $0.65   $(1.06)

 

12

 

 

Class A Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC 480.

 

Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A Ordinary Shares feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A Ordinary Shares subject to possible redemption are classified as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. Accordingly, as of September 30, 2023, 16,880,481 shares of Class A Ordinary Shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

 

The Class A Ordinary Shares subject to possible redemption are subject to the subsequent measurement guidance in ASC 480-10-S99. Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the ordinary shares is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the ordinary shares subject to possible redemption to their redemption amount (i.e., $10.30 per share) immediately as if the end of the first reporting period after the IPO, March 14, 2022, was the redemption date. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit. For the year ended December 31, 2022, the Company recorded an accretion of $27,928,643 of which $9,275,425 was recorded in additional paid-in capital and $18,653,218 was recorded in accumulated deficit.

 

At September 30, 2023, 16,880,481 ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

 

Gross proceeds  $230,000,000 
Less:     
Class A ordinary shares issuance costs   (13,465,157)
Fair value of Public Warrants at issuance   (4,151,500)
Plus:     
Accretion of carrying value to redemption value   27,928,643 
Class A ordinary shares subject to possible redemption at December 31, 2022  $240,311,986 
Remeasurement of carrying value to redemption value   8,801,882 
Redemption of Class A ordinary shares   (65,163,747)
Class A ordinary shares subject to possible redemption at September 30, 2023  $183,950,121 

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net- cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

13

 

 

Derivative Warrant Liabilities

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss under the caption change in fair value of derivative warrant liabilities on the unaudited condensed statements of operations. The warrants were valued using a Monte Carlo simulation model until the Class A ordinary shares and warrants began trading separately on May 4, 2022. Since May 4, 2022, the Public Warrants have been measured using the listed market price and the Private Placement Warrants have been measured by reference to the trading price of the Public Warrants.

 

The Class A Ordinary Shares and warrants comprising the units began separate trading on the 52nd day following the date of the IPO. No fractional warrants issued upon separation of the units and only whole warrants will trade. Accordingly, unless a multiple of two units is purchased, the number of warrants issuable to you upon separation of the units will be rounded down to the nearest whole number of warrants.

 

Additionally, the units will automatically separate into their component parts and will not be traded after completion of the Initial Business Combination.

 

Share-based Compensation

 

The Company accounts for Founder Shares issued to its independent directors in accordance with SEC Staff Accounting Bulletin 5T and ASC 718, “Compensation-Stock Compensation.” The fair value of the Founder Shares issued in this arrangement was determined using the implied stock price as of the date of Initial Public Offering of the Company’s Class A ordinary shares and the probability of the success of the Business Combination.

 

Offering Costs

 

Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are directly related to the IPO. Upon the completion of the IPO, the offering costs were allocated using the relative fair values of the Company’s Class A Ordinary Shares and its Public Warrants and Private Placement Warrants. The costs allocated to warrants were recognized in other expenses and those related to the Company’s Class A Ordinary Shares were charged against the carrying value of Class A Ordinary Shares. The Company complies with the requirements of the ASC 340-10-S99-1, “Other Assets and Deferred Costs.”

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and 2022, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties.

 

14

 

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. U.S. taxation could be imposed if the Company is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time. Additionally, given the nature of the investment income generated from the funds held in the trust account, it is not subject to tax withholdings in the U.S. Moreover, the Company determined that no income tax liability would arise from any other jurisdictions outside of the Cayman Islands. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

 

Recent Accounting Pronouncements

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020- 06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. As a result of ASU 2020 – 06, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost and more convertible preference shares will be accounted for as a single equity instrument measured at its historical cost, as long as no features require bifurcation and recognition as derivatives. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company is evaluating the impact of ASU 2020-06 on its financial statements.

 

The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.

 

Note 3 – Initial Public Offering

 

Pursuant to the IPO, the Company sold 23,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A Ordinary Share and one-half of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A Ordinary Shares at an exercise price of $11.50 per whole share.

 

The Company had granted the Underwriters in the IPO (the “Underwriters”) a 45-day option to purchase up to 3,000,000 additional Units to cover over-allotments, which was exercised in full on the IPO date.

 

On June 12, 2023, 6,119,519 Class A ordinary shares were redeemed by the Company’s shareholders in connection with the Extraordinary General Meeting mentioned in Note 1. Following such redemptions, 22,630,481 ordinary shares remained outstanding, consisting of 16,880,481 Class A ordinary shares and 5,750,000 Class B ordinary shares.

 

Note 4 – Private Placement Warrants

 

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 14,500,000 of Private Placement Warrants, including the overallotment option, at a price of $1.00 per Private Placement Warrant ($14,500,000 in the aggregate). Each Private Placement Warrant is exercisable to purchase one share of Class A Ordinary Shares at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. Upon the purchase of the Private Placement Warrants by the Sponsor, the Company recorded the excess proceeds received over the fair value of the Private Placement Warrants as additional paid-in capital amounting to $9,251,000.

 

15

 

 

Note 5 – Related Party Transactions

 

Founder Shares

 

On March 3, 2021, one of our officers paid $25,000, to cover certain of our offering costs, in exchange for an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”), which were temporarily issued to such officer until such shares were transferred to our sponsor in April 2021. Our Sponsor was formed on March 9, 2021. In February 2022, our Sponsor forfeited 1,437,500 Founder Shares for no consideration, remaining with 5,750,000 Founder Shares. Prior to the IPO, on March 9, 2022, our Sponsor transferred 30,000 of our Founder Shares to each of our three independent directors. These 90,000 shares were not subject to forfeiture. The allocation of the Founder Shares to the directors is in the scope of ASC 718. Under ASC 718, share-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Company used the Monte Carlo model to estimate the fair value associated with the Founder Shares granted. The fair value of the 90,000 shares granted to the Company’s directors in March 2022 was $662,245 or $7.36 per share. The Founder Shares were granted subject to a performance condition, the occurrence of an Initial Business Combination. Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence under ASC 718. The Company determined the performance conditions are not considered probable, and, therefore, no share-based compensation expense was recognized for period ended September 30, 2023 and 2022. As of September 30, 2023 and 2022, the unrecognized stock compensation expense was $662,245.

 

On March 14, 2022, the underwriters fully exercised the over-allotment option; thus, the 750,000 Founder Shares are no longer subject to forfeiture.

 

The Sponsor has agreed not to transfer, assign or sell any of their founder shares and any Class A Ordinary Shares issued upon conversion thereof until the earlier to occur of (A) one year after the completion of our initial business combination; or (B) subsequent to our initial business combination, (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date following the completion of our initial business combination on which we complete a liquidation, merger, amalgamation, stock exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property.

 

The Founder Shares will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation of the Company’s Initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Ordinary Shares or equity-linked securities are issued or deemed issued in connection with the Company’s Initial Business Combination, the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A Ordinary Shares outstanding after such conversion (after giving effect to any redemptions of Class A Ordinary Shares by Public Shareholders), including the total number of Class A Ordinary Shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the Initial Business Combination, excluding any Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, or to be issued, to any seller in the Initial Business Combination and any Private Placement Warrants issued to the Sponsor, or the Company’s officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

 

Promissory Note – Related Party

 

On March 3, 2021, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $250,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) March 31, 2023, and (ii) the completion of the IPO. On January 31, 2022, the Company amended the unsecured Promissory Note to provide an additional borrowing of $250,000, for a total borrowing capacity of $500,000. Promissory note balance as of December 31, 2021 was $437,508 which was fully paid upon the Company’s consummation of its initial public offering. There is no outstanding balance on the promissory note as of March 31, 2023 and December 31, 2022, respectively.

 

16

 

 

Due to Related Party

 

As of September 30, 2023 and December 31, 2022, the Company had an outstanding balance of $1,2000,000 and $3,144 due to the Sponsor related to expenses paid by the Sponsor on behalf of the Company. This amount is due on demand. During the year ended December 31, 2022, the Company borrowed $150,334 from the Sponsor, all of which was repaid except the outstanding balance of $3,144. As of September 30, 2023, the Company has deposited an aggregate of $1,200,000 into the Trust Account in the form of a loan in connection with the extension of the termination date for an additional four-month period, from June 14, 2023 to October 14, 2023. The loan has no interest and is forgiven should the Company not complete an initial business combination. The Sponsor is committed to extending the $300,000 monthly loan to the Company till the earlier of liquidation date or the consummation of an initial business combination. On October 10, 2023, the Company borrowed additional $300,000 from its Sponsor and deposited such into the Trust Account as extension deposit through November 14, 2023. On November 13, 2023, the Company made additional deposit of $300,000 representing extension payment through December 14, 2023.

 

Administrative Services Agreement

 

Following our IPO, the Company pays the Sponsor or an affiliate a monthly fee of $10,000 for office space, utilities, secretarial and administrative services. In August 2023, the Company and its Sponsor executed an agreement to discontinue the remittance of administrative fees to the Sponsor with an effective date of August 1, 2023. For the three and nine months ended September 30, 2023, the Company incurred and paid $0 and $60,000 in administrative support fees, respectively. For the three and nine months ended September 30, 2022, the Company incurred and paid $30,000 and $65,484   in administrative support fees, respectively.

 

Working Capital Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2023 and December 31, 2022, the Company had no borrowings under the Working Capital Loans.

 

Note 6 – Commitments and Contingencies

 

Registration Rights

 

The holders of Founder Shares and Private Placement Warrants, including any that may be issued upon conversion of Working Capital Loans, if any (and any Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants, including any that may be issued upon conversion of the Working Capital Loans), will be entitled to registration rights pursuant to a registration rights agreement entered into prior to the consummation of the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company is not required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to an additional 3,000,000 Units to cover over-allotments. The underwriter fully exercised its over-allotment option concurrently with the close of the IPO. The underwriter was entitled to a cash underwriting discount of $0.20 per Unit (or $4,600,000) of the gross proceeds of the IPO. Additionally, the underwriter is entitled to a deferred underwriting commission of $0.35 per Unit (or $8,050,000) of the gross proceeds of the IPO upon the completion of the Company’s Initial Business Combination. The deferred underwriting commissions will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement.

 

17

 

 

Note 7 – Derivative Warrant Liabilities

 

The Company accounted for the 26,000,000 Warrants issued in connection with the IPO (the 11,500,000 of Public Warrants and the 14,500,000 of Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the Warrants do not meet the criteria for equity treatment thereunder, each Warrant much be recorded as a liability. Accordingly, the Company classifies each Warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s unaudited condensed statements of operations.

 

Each whole Warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. Only whole Warrants are exercisable. The Warrants will become exercisable 30 days after the completion of the Initial Business Combination and will expire five years after the completion of the Initial Business Combination or earlier upon redemption or liquidation.

 

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of an Initial Business Combination provided that the Company has an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or holders are permitted to exercise their Public Warrants on a cashless basis under certain circumstances as a result of (i) the Company’s failure to have an effective registration statement by the 60th business day after the closing of the Initial Business Combination or (ii) a notice of redemption described under “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00”). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of its Initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the IPO or a new registration statement covering the Class A Ordinary Shares issuable upon exercise of the Warrants and will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the Company’s Initial Business Combination and to maintain a current prospectus relating to those Class A Ordinary Shares until the Warrants expire or are redeemed. If the shares issuable upon exercise of the Public Warrants are not registered under the Securities Act in accordance with the above requirements, the Company will be required to permit holders to exercise their Public Warrants on a cashless basis. However, no Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. Notwithstanding the above, if the Company’s Class A Ordinary Shares are at the time of any exercise of a Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

 

The Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00” and “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

 

The Private Placement Warrants are identical to the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees, (i) they will not be redeemable by the Company, (ii) they (including the Class A Ordinary Shares issuable upon exercise of these Warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Initial Business Combination, (iii) they may be exercised by the holders on a cashless basis, (iv) are subject to registration rights and (v) use a different Black-Scholes Warrant Model for purposes of calculating the Black-Scholes Warrant Value (as defined in the warrant agreement).

 

18

 

 

On the exercise of any Warrant, the Warrant exercise price will be paid directly to us and not placed in the Trust Account.

 

Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except as described herein with respect to the Private Placement Warrants):

 

  in whole and not in part;

 

  at a price of $0.01 per Warrant;

 

  upon a minimum of 30 days’ prior written notice of redemption; and

 

  if, and only if, the last reported sale price of Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

 

The Company will not redeem the Warrants as described above unless an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Warrants is effective and a current prospectus relating to those Class A Ordinary Shares is available throughout the 30-day redemption period. Any such exercise would not be on a cashless basis and would require the exercising warrant holder to pay the exercise price for each Warrant being exercised.

 

Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants:

 

  in whole and not in part;

 

  at a price of $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth in the warrant agreement based on the redemption date and the “redemption fair market value” of Class A Ordinary Shares (as defined below) except as otherwise described in the warrant agreement;

 

  if, and only if, the closing price of Class A Ordinary Shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and

 

  if the closing price of the Class A Ordinary Shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

 

Solely for the purposes of this redemption provision, the “redemption fair market value” of the Company’s Class A Ordinary Shares shall mean the volume weighted average price of the Class A Ordinary Shares for the ten (10) trading days immediately following the date on which notice of redemption is sent to the holders of Warrants.

 

No fractional Class A Ordinary Shares issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A Ordinary Shares to be issued to the holder.

 

19

 

 

Note 8 – Shareholder’s Deficit

 

Preference Shares The Company is authorized to issue 1,000,000 preference shares, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.

 

Class A Ordinary Shares – The Company is authorized to issue 200,000,000 Class A Ordinary Shares with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were 16,880,481 and 23,000,000 shares, respectively, of Class A Ordinary Shares issued and outstanding that are subject to possible redemption.

 

Class B Ordinary Shares – The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, 5,750,000 Class B ordinary shares were issued and outstanding.

 

Holders of the Class A Ordinary Shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares shall have the right to vote on the appointment and removal of the Company’s directors prior to the Initial Business Combination or continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents of the Company or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands).

 

Note 9 – Fair Value Measurements

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023.

 

   Level 1   Level 2   Level 3   Total 
Assets                
Marketable securities held in Trust Account  $183,950,121   $
   $
   $183,950,121 
   $183,950,121   $
   $
   $183,950,121 
Liabilities                    
Public Warrants  $690,000   $
   $
   $690,000 
Private Placement Warrants   
    870,000    
    870,000 
Total liabilities  $690,000   $870,000   $
   $1,560,000 

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022, including the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

 

   Level 1   Level 2   Level 3   Total 
Assets                
Investments held in Trust Account  $240,311,986   $
   $
   $240,311,986 
Total assets  $240,311,986   $
   $
   $240,311,986 
                     
Liabilities                    
Public Warrants  $1,035,000   $
   $
   $1,035,000 
Private Placement Warrants  $
   $1,305,000    
    1,305,000 
Total liabilities  $1,035,000   $1,305,000   $
   $2,340,000 

 

The Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting date. Changes in the fair value of the Warrants are recorded in the statements of operations each period.

 

20

 

 

Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. During the quarter ended September 30, 2023 there were no transfers to/from any level. During the year ended December 31, 2022, the public and private warrants were transferred out of level 3 into level 1 and level 2, respectively. See the table below to illustrate the transfers out of level 3.

 

Level 3 warrant liabilities at January 1, 2022  $
 
Addition at March 14, 2022   9,400,500 
Change in fair value of warrant liabilities   (7,060,500)
Transfers from level 3 to level 2 instruments   (1,305,000)
Transfers from level 3 to level 1 instruments   (1,035,000)
Level 3 warrant liabilities at December 31, 2022  $
 

 

The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model. The fair value of Public Warrants issued in connection with the Initial Public Offering was measured based on the listed market price of such warrants, a Level 1 measurement, since May 4, 2022. The fair value of the Private Placement Warrants has subsequently been measured by reference to the trading price of the Public Warrants, which is considered to be a Level 2 fair value measurement. The Company recognized change in the fair value of warrant liabilities of $353,600 and $780,000, which are presented as changes in fair value of derivative warrant liabilities on the accompanying unaudited condensed statements of operations for the three and nine months ended September 30, 2023, respectively. The Company recognized a change in the fair value of warrant liabilities of $7,060,500, which is presented as change in fair value of derivative warrant liabilities on the statements of operations for the year ended December 31, 2022.

 

The following table provides quantitative information regarding Level 3 fair value measurement inputs for the Public Warrants and Private Placement Warrants at their measurement date:

 

   March 14,
2022
 
   (IPO date) 
Exercise Price  $11.50 
Underlying share price  $9.82 
Volatility   5.4%
Term to Business Combination (years)   6.05 
Risk-free rate   2.13%

 

The table below shows the change in fair value of the derivative warrant liabilities as of September 30, 2023:

 

   Private
Warrant
   Public
Warrant
   Total 
Fair value at January 1, 2023  $1,305,000   $1,035,000   $2,340,000 
Change in fair value   (435,000)   
(345,00
)   (780,000)
Fair value as of September 30, 2023  $870,000   $690,000   $1,560,000 

 

The table below shows the change in fair value of the derivative warrant liabilities as of September 30, 2022:

 

   Private
Warrant
   Public
Warrant
   Total 
Fair value at January 1, 2022  $
   $
   $
 
Fair value at March 14, 2022   4,151,500    5,249,000    9,400,500 
Change in fair value   2,081,500    2,639,000    4,720,500 
Fair value as of September 30, 2022  $2,070,000   $2,610,000   $4,680,000 

 

21

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Patria Latin American Opportunity Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to Patria SPAC LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company incorporated in Cayman Islands on February 25, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, ordinary share purchase, reorganization or similar business combination with one or more businesses, or the “Business Combination.” The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

22

 

 

Initial Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commission held in Trust and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company only intends to complete a Business Combination if the post-business combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the IPO, management has agreed that an amount equal to at least $10.30 per Unit sold in the IPO, including the proceeds from the sale of the Private Placement Warrants, will be held in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company will provide the holders (the “Public Shareholders”) of the Company’s issued and outstanding Class A ordinary shares, par value $0.0001 per share, sold in the IPO (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Public Shares for a pro rata portion of the amount then held in the Trust Account. The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. If the Company seeks shareholder approval, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Articles of Association (the “Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below) and any Public Shares purchased during or after the IPO in favor of a Business Combination. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

 

The Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The holders of the Founder Shares (the “initial shareholders”) have agreed not to propose an amendment to the Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

 

If the Company is unable to complete a Business Combination within 15 months from the closing of the IPO (or up to within 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus) of the IPO (the “Combination Period”) and the Company’s shareholders have not amended the Articles of Association to extend such Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman law to provide for claims of creditors and the requirements of other applicable law.

 

23

 

 

The initial shareholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares after the IPO, they will be entitled to liquidating distributions from the Trust if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.30. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.30 per unit or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities from February 25, 2021 (inception) through September 30, 2023 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and the Company’s search for a target business with which to complete a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We generate non-operating income in the form of realized gains on the investments held in the trust account. We are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a Business Combination.

 

For the nine months ended September 30, 2023 we reported net income of $7,453,331 which consists of general and administrative expenses of $928,551 (made up of professional services fees of $442,116 and other general and administrative fees of $486,435), change in fair value of derivative warrant liabilities of $780,000 and realized gain on the investments held in the trust account of $7,601,882.

 

For the nine months ended September 30, 2022 we reported net income of $5,080,880 which consists of general and administrative expenses of $728,577 (made up of professional services fees of $305,111 and other general and administrative fees of $423,466), change in fair value of derivative warrant liabilities of $4,720,500 gain on the investments held in the Trust Account of $1,403,465 and transaction costs allocated to derivative warrant liabilities of $314,508.

 

For the three months ended September 30, 2023 we reported net income of $1,766,214 which consists of general and administrative expenses of $241,063 (made up of professional services fees of $75,095 and other general and administrative fees of $165,968), change in fair value of derivative warrant liabilities of $(353,600) and realized gain on the investments held in the trust account of $2,360,877.

 

For the three months ended September 30, 2022 we reported net loss of $(438,683) which consists of general and administrative expenses of $240,538 (made up of professional services fees of $145,488, and other general and administrative fees of $95,050), change in fair value of derivative warrant liabilities of $(1,300,000), gain on the investments held in the Trust Account of $1,101,855 and transaction costs allocated to derivative warrant liabilities of $0.

 

24

 

 

Liquidity and Going Concern Consideration

 

As of September 30, 2023, the Company had working capital of $173,155,304 including the Trust Account, deferred underwriting fees payable. Working capital was $(1,184,817) when marketable securities held in Trust Account, deferred underwriting fees payable, and derivative warrant liabilities were excluded from the calculation. Of the net proceeds from the IPO and associated sale of Private Placement Warrants, $236,900,000 of cash was placed in the Trust Account. The working capital surplus includes the amount of restricted marketable securities held in the Trust Account, deferred underwriting fees payable and derivative warrant liabilities, all of which have been classified as current at September 30, 2023 as a result of the Company being less than 12 months away from consuming the assets held in the Trust Account to either consummate a business combination or to liquidate.

 

For the nine months ended September 30, 2023, cash used in operating activities was $522,362, which is made up of a net income of $7,453,331, changes in operating assets and liabilities of $406,189. These amounts were offset by a gain on Investments held in the Trust account of $7,601,882 and change in fair value of derivative warrant liabilities of $780,000. Cash of $182,243 was held outside of the Trust Account and is available for the Company’s working capital purposes.

 

As of September 30, 2023, we had cash of $182,243. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete a Business Combination.

 

In order to finance transaction costs in connection with an Initial Business Combination, the Company’s sponsor, or an affiliate of the sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide Working Capital Loans to the Company. As of September 30, 2023, there were no amounts outstanding under any Working Capital Loans.

 

If the Company’s estimates of the costs of identifying a target business, undertaking due diligence and negotiating an Initial Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to an Initial Business Combination. Moreover, the Company may need to obtain additional financing either to complete an Initial Business Combination or because it becomes obligated to redeem a significant number of its Public Shares upon completion of an Initial Business Combination, in which case the Company may issue additional securities or incur debt in connection with such Initial Business Combination.

 

The Company anticipates that the cash held outside of the Trust Account as of September 30, 2023 will not be sufficient to allow the Company to operate for at least the next 12 months from the issuance of the unaudited condensed financial statements, assuming that a Business Combination is not consummated during that time. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued. Management plans to address this uncertainty through the Business Combination as discussed above. In addition, the sponsor or an affiliate of the sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required under the Working Capital Loans. There is no assurance that the Company’s plans to consummate the Business Combination will be successful or successful within the Combination Period or that the sponsor or an affiliate of the sponsor, or certain of the Company’s officers and directors will loan the Company funds as may be required under the Working Capital Loans.

 

The unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

25

 

 

Commitments and Contractual Obligations

 

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.

 

The underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement.

 

Administrative Services Agreement

 

Following our IPO, the Company pays the Sponsor or an affiliate a monthly fee of $10,000 for office space, utilities, secretarial and administrative services. In August 2023, the Company and its Sponsor executed an agreement to discontinue the remittance of administrative fees to the Sponsor with an effective date of August 1, 2023.For the three and nine months ended September 30, 2023, we incurred and paid $0 and $60,000 in administrative support fees. For the three and nine months ended September 30, 2022, we incurred and paid $30,000 and $65,484 in administrative support fees.

 

Registration Rights

 

The holders of Founder Shares and Private Placement Warrants, including any that may be issued upon conversion of Working Capital Loans, if any (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants, including any that may be issued upon conversion of the Working Capital Loans), will be entitled to registration rights pursuant to a registration rights agreement entered into prior to the consummation of the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company is not required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Critical Accounting Estimates

 

The preparation of the unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting estimates.

 

Recent Accounting Standards

 

See “Recent Accounting Pronouncements” in Note 2 of the accompanying unaudited condensed financial statements.

 

JOBS Act

 

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the unaudited condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

 

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the unaudited condensed financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

 

26

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our current chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2023, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of September 30, 2023, our disclosure controls and procedures were effective.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

27

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in in the Company’s annual report on Form 10-K as filed with the SEC on March 31, 2023. As of the date of this Report, there have been no material changes to the risk factors disclosed in our final prospectus filed with the SEC other than the additional risk factor set forth in our quarterly report on Form 10-Q filed with the SEC on May 5, 2022.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On March 14, 2022, we consummated the Initial Public Offering of 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover over-allotments. The Units sold were sold at an offering price of $10.00 per unit, generating total gross proceeds of $230,000,000. JP Morgan Securities LLC and Citigroup Global Markets Inc. JP Morgan Securities LLC and Citigroup Global Markets Inc. acted as joint book-running managers for the offering. The securities in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-254498). The Securities and Exchange Commission declared the registration statement effective on March 9, 2022.

 

Simultaneously with the consummation of the Initial Public Offering and the full exercise of the over-allotment option, we consummated the private placement of an aggregate of 14,500,000 warrants at a price of $1.00 per Private Placement Warrant, generating total proceeds of $14,500,000 The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

 

The Private Placement Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

 

Of the gross proceeds received from the Initial Public Offering, the full exercise of the over-allotment option and the sale of the Private Placement Warrants, $236,900,000 was placed in the Trust Account.

 

We accrued a total of $13,779,665 in transaction costs, including $8,050,000 in deferred underwriting fees, $4,600,000 in upfront underwriting fees, and other offering costs of $1,129,665 related to the Initial Public Offering.

 

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable

 

Item 5. Other Information

 

None.

 

28

 

 

Item 6. Exhibits

 

No.   Description of Exhibit
31.1*   Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**   Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

* Filed herewith.

 

** These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

29

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.
       
Date: November 13, 2023  By: /s/ José Augusto Gonçalves de Araújo Teixeira
    Name:  José Augusto Gonçalves de Araújo Teixeira
    Title: Chief Executive Officer

 

 

30

 

 

00-0000000 KY 16880481 16934066 20511844 23000000 0.01 0.13 0.38 0.65 5552198 5750000 5750000 5750000 0.05 0.05 0.07 1.06 16880481 23000000 5750000 5750000 0.01 0.05 0.07 0.13 16934066 20511844 5552198 5750000 0.05 0.38 0.65 1.06 12000000 34500 false --12-31 Q3 0001849737 0001849737 2023-01-01 2023-09-30 0001849737 plao:UnitsEachConsistingOfOneClassAOrdinaryShare00001ParValueAndOnehalfOfOneRedeemableWarrantMember 2023-01-01 2023-09-30 0001849737 plao:ClassAOrdinarySharesIncludedAsPartOfTheUnitsMember 2023-01-01 2023-09-30 0001849737 plao:RedeemableWarrantsIncludedAsPartOfTheUnitsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member 2023-01-01 2023-09-30 0001849737 us-gaap:CommonClassAMember 2023-11-13 0001849737 us-gaap:CommonClassBMember 2023-11-13 0001849737 2023-09-30 0001849737 2022-12-31 0001849737 us-gaap:RelatedPartyMember 2023-09-30 0001849737 us-gaap:RelatedPartyMember 2022-12-31 0001849737 us-gaap:CommonClassAMember 2023-09-30 0001849737 us-gaap:CommonClassAMember 2022-12-31 0001849737 us-gaap:CommonClassBMember 2023-09-30 0001849737 us-gaap:CommonClassBMember 2022-12-31 0001849737 2023-07-01 2023-09-30 0001849737 2022-07-01 2022-09-30 0001849737 2022-01-01 2022-09-30 0001849737 us-gaap:CommonClassAMember 2023-07-01 2023-09-30 0001849737 us-gaap:CommonClassAMember 2022-07-01 2022-09-30 0001849737 us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001849737 us-gaap:CommonClassAMember 2022-01-01 2022-09-30 0001849737 us-gaap:CommonClassBMember 2023-07-01 2023-09-30 0001849737 us-gaap:CommonClassBMember 2022-07-01 2022-09-30 0001849737 us-gaap:CommonClassBMember 2023-01-01 2023-09-30 0001849737 us-gaap:CommonClassBMember 2022-01-01 2022-09-30 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2022-12-31 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001849737 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001849737 us-gaap:RetainedEarningsMember 2022-12-31 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2023-01-01 2023-03-31 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001849737 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001849737 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001849737 2023-01-01 2023-03-31 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2023-03-31 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001849737 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001849737 us-gaap:RetainedEarningsMember 2023-03-31 0001849737 2023-03-31 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2023-04-01 2023-06-30 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001849737 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001849737 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001849737 2023-04-01 2023-06-30 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2023-06-30 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-06-30 0001849737 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001849737 us-gaap:RetainedEarningsMember 2023-06-30 0001849737 2023-06-30 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2023-07-01 2023-09-30 0001849737 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2023-09-30 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-09-30 0001849737 us-gaap:RetainedEarningsMember 2023-09-30 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2021-12-31 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001849737 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001849737 us-gaap:RetainedEarningsMember 2021-12-31 0001849737 2021-12-31 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2022-01-01 2022-03-31 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001849737 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001849737 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001849737 2022-01-01 2022-03-31 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2022-03-31 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001849737 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001849737 us-gaap:RetainedEarningsMember 2022-03-31 0001849737 2022-03-31 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2022-04-01 2022-06-30 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001849737 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001849737 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001849737 2022-04-01 2022-06-30 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2022-06-30 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-06-30 0001849737 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001849737 us-gaap:RetainedEarningsMember 2022-06-30 0001849737 2022-06-30 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2022-07-01 2022-09-30 0001849737 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001849737 us-gaap:CommonClassAMember plao:OrdinarySharesSubjectToPossibleRedemptionMember 2022-09-30 0001849737 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-09-30 0001849737 us-gaap:RetainedEarningsMember 2022-09-30 0001849737 2022-09-30 0001849737 us-gaap:IPOMember 2022-03-14 2022-03-14 0001849737 us-gaap:OverAllotmentOptionMember 2022-03-14 2022-03-14 0001849737 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-03-14 0001849737 us-gaap:CommonClassAMember 2022-03-14 0001849737 2022-03-14 0001849737 us-gaap:CommonClassAMember 2022-03-14 2022-03-14 0001849737 us-gaap:PrivatePlacementMember 2023-09-30 0001849737 us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001849737 2022-03-14 2022-03-14 0001849737 us-gaap:IPOMember 2022-03-14 0001849737 us-gaap:PrivatePlacementMember 2022-03-14 2022-03-14 0001849737 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-09-30 0001849737 us-gaap:CommonClassAMember 2023-06-14 2023-06-14 0001849737 2023-07-12 2023-07-12 0001849737 us-gaap:SubsequentEventMember 2023-10-01 2023-10-10 0001849737 us-gaap:SubsequentEventMember 2023-11-01 2023-11-13 0001849737 plao:InitialBusinessCombinationMember 2023-09-30 0001849737 us-gaap:IPOMember 2023-09-30 0001849737 plao:TrustAccountMember 2023-09-30 0001849737 2022-01-01 2022-12-31 0001849737 us-gaap:CommonClassAMember 2022-01-01 2022-12-31 0001849737 us-gaap:IPOMember 2023-01-01 2023-09-30 0001849737 us-gaap:OverAllotmentOptionMember 2023-01-01 2023-09-30 0001849737 us-gaap:CommonClassAMember 2023-06-12 2023-06-12 0001849737 2023-06-12 0001849737 us-gaap:CommonClassAMember 2023-06-12 0001849737 us-gaap:CommonClassBMember 2023-06-12 0001849737 plao:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2023-09-30 0001849737 plao:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2023-01-01 2023-09-30 0001849737 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2023-09-30 0001849737 plao:FounderSharesMember plao:SponsorMember us-gaap:CommonClassBMember 2021-03-03 2021-03-03 0001849737 plao:FounderSharesMember plao:SponsorMember us-gaap:CommonClassBMember 2021-03-01 2021-03-03 0001849737 plao:FounderSharesMember plao:SponsorMember 2022-02-28 0001849737 plao:FounderSharesMember plao:SponsorMember 2022-02-01 2022-02-28 0001849737 plao:FounderSharesMember plao:SponsorMember 2022-03-09 0001849737 plao:FounderSharesMember 2023-09-30 0001849737 plao:SponsorMember us-gaap:CommonClassAMember 2023-09-30 0001849737 plao:FounderSharesMember plao:SponsorMember us-gaap:CommonClassAMember 2023-01-01 2023-09-30 0001849737 2021-03-03 0001849737 plao:PromissoryNoteRelatedPartyMember 2022-01-01 2022-01-31 0001849737 plao:PromissoryNoteRelatedPartyMember 2022-01-31 0001849737 us-gaap:RelatedPartyMember plao:SponsorMember 2023-09-30 0001849737 2023-10-10 0001849737 plao:SponsorMember 2023-01-01 2023-09-30 0001849737 plao:AdministrativeSupportAgreementMember 2023-07-01 2023-09-30 0001849737 plao:AdministrativeSupportAgreementMember 2023-01-01 2023-09-30 0001849737 plao:AdministrativeSupportAgreementMember 2022-07-01 2022-09-30 0001849737 plao:AdministrativeSupportAgreementMember 2022-01-01 2022-09-30 0001849737 plao:WorkingCapitalLoansMember 2023-09-30 0001849737 plao:UnderwritingAgreementMember 2023-01-01 2023-09-30 0001849737 plao:PublicWarrantsMember 2023-09-30 0001849737 plao:PrivatePlacementWarrantsMember 2023-09-30 0001849737 us-gaap:CommonClassAMember us-gaap:NoteWarrantMember 2023-09-30 0001849737 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001849737 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001849737 us-gaap:FairValueInputsLevel2Member 2023-09-30 0001849737 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001849737 us-gaap:FairValueInputsLevel1Member plao:PublicWarrantsMember 2023-09-30 0001849737 us-gaap:FairValueInputsLevel2Member plao:PublicWarrantsMember 2023-09-30 0001849737 us-gaap:FairValueInputsLevel3Member plao:PublicWarrantsMember 2023-09-30 0001849737 us-gaap:FairValueInputsLevel1Member us-gaap:PrivatePlacementMember 2023-09-30 0001849737 us-gaap:FairValueInputsLevel2Member us-gaap:PrivatePlacementMember 2023-09-30 0001849737 us-gaap:FairValueInputsLevel3Member us-gaap:PrivatePlacementMember 2023-09-30 0001849737 us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-09-30 0001849737 us-gaap:FairValueInputsLevel2Member 2023-01-01 2023-09-30 0001849737 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-09-30 0001849737 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001849737 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001849737 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001849737 us-gaap:FairValueInputsLevel1Member plao:PublicWarrantsMember 2022-12-31 0001849737 us-gaap:FairValueInputsLevel2Member plao:PublicWarrantsMember 2022-12-31 0001849737 us-gaap:FairValueInputsLevel3Member plao:PublicWarrantsMember 2022-12-31 0001849737 plao:PublicWarrantsMember 2022-12-31 0001849737 us-gaap:FairValueInputsLevel1Member us-gaap:PrivatePlacementMember 2022-12-31 0001849737 us-gaap:FairValueInputsLevel2Member us-gaap:PrivatePlacementMember 2022-12-31 0001849737 us-gaap:FairValueInputsLevel3Member us-gaap:PrivatePlacementMember 2022-12-31 0001849737 us-gaap:PrivatePlacementMember 2022-12-31 0001849737 us-gaap:FairValueInputsLevel1Member 2022-01-01 2022-12-31 0001849737 us-gaap:FairValueInputsLevel2Member 2022-01-01 2022-12-31 0001849737 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001849737 2022-03-14 2022-12-31 0001849737 plao:TransfersFromLevel3ToLevel2InstrumentsMember 2022-12-31 0001849737 plao:TransfersFromLevel3ToLevel1InstrumentsMember 2022-12-31 0001849737 plao:PublicWarrantsMember 2023-01-01 2023-09-30 0001849737 us-gaap:PrivatePlacementMember 2021-12-31 0001849737 plao:PublicWarrantsMember 2021-12-31 0001849737 us-gaap:PrivatePlacementMember 2022-03-14 2022-09-30 0001849737 plao:PublicWarrantsMember 2022-03-14 2022-09-30 0001849737 2022-03-14 2022-09-30 0001849737 us-gaap:PrivatePlacementMember 2022-09-30 0001849737 plao:PublicWarrantsMember 2022-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, José Augusto Gonçalves de Araújo Teixeira, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Patria Latin American Opportunity Acquisition Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2023 By: /s/ José Augusto Gonçalves de Araújo Teixeira
    Name: José Augusto Gonçalves de Araújo Teixeira
    Title: Chief Executive Officer

 

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Ana Cristina Russo, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Patria Latin American Opportunity Acquisition Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 13, 2023 By: /s/ Ana Cristina Russo
    Name: Ana Cristina Russo
    Title: Chief Financial Officer

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Patria Latin American Opportunity Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, José Augusto Gonçalves de Araújo Teixeira, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 13, 2023 By: /s/ José Augusto Gonçalves de Araújo Teixeira
    Name: José Augusto Gonçalves de Araújo Teixeira
    Title: Chief Executive Officer

 

Exhibit 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Patria Latin American Opportunity Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ana Cristina Russo, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 13, 2023 By: /s/ Ana Cristina Russo
    Name: Ana Cristina Russo
    Title: Chief Financial Officer

 

 

v3.23.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2023
Nov. 13, 2023
Document Information Line Items    
Entity Registrant Name PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Amendment Flag false  
Entity Central Index Key 0001849737  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company true  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-41321  
Entity Incorporation, State or Country Code E9  
Entity Tax Identification Number 00-0000000  
Entity Address, Address Line One 18 Forum Lane  
Entity Address, Address Line Two 3rd floor  
Entity Address, Address Line Three Camana Bay, PO Box 757  
Entity Address, Country KY  
Entity Address, City or Town Grand Cayman  
Entity Address, Postal Zip Code KY1-9006  
City Area Code +1 345  
Local Phone Number 640 4900  
Entity Interactive Data Current Yes  
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant    
Document Information Line Items    
Trading Symbol PLAOU  
Title of 12(b) Security Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant  
Security Exchange Name NASDAQ  
Class A ordinary shares, included as part of the units    
Document Information Line Items    
Trading Symbol PLAO  
Title of 12(b) Security Class A ordinary shares, included as part of the units  
Security Exchange Name NASDAQ  
Redeemable warrants, included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50    
Document Information Line Items    
Trading Symbol PLAOW  
Title of 12(b) Security Redeemable warrants, included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50  
Security Exchange Name NASDAQ  
Class A Ordinary Shares    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   16,880,481
Class B Ordinary Shares    
Document Information Line Items    
Entity Common Stock, Shares Outstanding   5,750,000
v3.23.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
ASSETS    
Cash $ 182,243 $ 707,749
Prepaid expenses 133,855 307,756
Marketable securities held in Trust Account 183,950,121 240,311,986
Total current assets 184,266,219 241,327,491
Total Assets 184,266,219 241,327,491
Current liabilities:    
Accounts payable 226,158
Accrued expenses 74,757 68,627
Derivative warrant liabilities 1,560,000 2,340,000
Deferred underwriting fees payable 8,050,000 8,050,000
Total current liabilities 11,110,915 10,461,771
Total liabilities 11,110,915 10,461,771
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption, $0.0001 par value; 16,880,481 and 23,000,000 shares at $10.90 and 10.45 per share at September 30, 2023 and December 31, 2022, respectively 183,950,121 240,311,986
Shareholders’ deficit    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital
Accumulated deficit (10,795,392) (9,446,841)
Total shareholders’ deficit (10,794,817) (9,446,266)
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit 184,266,219 241,327,491
Class A Ordinary Shares    
Current liabilities:    
Class A ordinary shares subject to possible redemption, $0.0001 par value; 16,880,481 and 23,000,000 shares at $10.90 and 10.45 per share at September 30, 2023 and December 31, 2022, respectively 183,950,121 240,311,986
Shareholders’ deficit    
Ordinary shares value
Class B Ordinary Shares    
Shareholders’ deficit    
Ordinary shares value 575 575
Related Party    
Current liabilities:    
Due to related party $ 1,200,000 $ 3,144
v3.23.3
Condensed Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Subject to possible redemption, Shares 16,880,481 23,000,000
Subject to possible redemption, par value (in Dollars per share) $ 0.0001 $ 0.0001
Subject to possible redemption, per share (in Dollars per share) 10.9 10.45
Preference shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preference shares, shares authorized 1,000,000 1,000,000
Preference shares, shares issued
Preference shares, shares outstanding
Class A Ordinary Shares    
Subject to possible redemption, Shares 16,880,481 23,000,000
Ordinary shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, authorized 200,000,000 200,000,000
Ordinary shares, issued
Ordinary shares, outstanding
Class B Ordinary Shares    
Ordinary shares, par value (in Dollars per share) $ 0.0001 $ 0.0001
Ordinary shares, authorized 20,000,000 20,000,000
Ordinary shares, issued 5,750,000 5,750,000
Ordinary shares, outstanding 5,750,000 5,750,000
v3.23.3
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
General and administrative expenses $ 241,063 $ 240,538 $ 928,551 $ 728,577
Loss from operations (241,063) (240,538) (928,551) (728,577)
Change in fair value of derivative warrant liabilities (353,600) (1,300,000) 780,000 4,720,500
Realized gain on investments held in Trust Account 2,360,877 1,101,855 7,601,882 1,403,465
Transaction costs allocated to derivative warrant liabilities (314,508)
Net income 1,766,214 (438,683) 7,453,331 5,080,880
Class A Ordinary Shares        
Net income $ 2,145,981 $ (130,575) $ 7,748,595 $ 10,966,644
Weighted average shares outstanding, basic (in Shares) 16,880,481 23,000,000 20,511,844 16,934,066
Basic net income (loss) per share (in Dollars per share) $ 0.13 $ (0.01) $ 0.38 $ 0.65
Class B Ordinary Shares        
Net income $ (379,767) $ (308,108) $ (295,264) $ (5,885,764)
Weighted average shares outstanding, basic (in Shares) 5,750,000 5,750,000 5,750,000 5,552,198
Basic net income (loss) per share (in Dollars per share) $ (0.07) $ (0.05) $ (0.05) $ (1.06)
v3.23.3
Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A Ordinary Shares        
Weighted average shares outstanding, diluted 16,880,481 23,000,000 20,511,844 16,934,066
Diluted net income (loss) per share $ 0.13 $ (0.01) $ 0.38 $ 0.65
Class B Ordinary Shares        
Weighted average shares outstanding, diluted 5,750,000 5,750,000 5,750,000 5,552,198
Diluted net income (loss) per share $ (0.07) $ (0.05) $ (0.05) $ (1.06)
v3.23.3
Condensed Statements of Changes in Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit (Unaudited) - USD ($)
Class A
Ordinary Shares Subject to Possible Redemption
Class A
Class B
Ordinary Shares
Class B
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021   $ 575   $ 24,425 $ (49,868) $ (24,868)
Balance (in Shares) at Dec. 31, 2021   5,750,000        
Proceeds from the sale of Class A Units $ 230,000,000    
Proceeds from the sale of Class A Units (in Shares) 23,000,000          
Paid underwriters fees $ (4,600,000)    
Deferred underwriting fees payable (8,050,000)    
Liability-classified equity instruments - Public Warrants (4,151,500)            
Other offering costs (815,157)      
Excess cash received over fair value of Private Placement Warrants     9,251,000 9,251,000
Accretion of Class A ordinary shares to redemption value 24,483,533     (9,275,425) (15,208,108) (24,483,533)
Net income (loss)     (829,640) (829,640)
Balance at Mar. 31, 2022 $ 236,866,876   $ 575   (16,087,616) (16,087,041)
Balance (in Shares) at Mar. 31, 2022 23,000,000   5,750,000        
Balance at Dec. 31, 2021   $ 575   24,425 (49,868) (24,868)
Balance (in Shares) at Dec. 31, 2021   5,750,000        
Net income (loss)   $ 10,966,644   $ (5,885,764)     5,080,880
Balance at Sep. 30, 2022 $ 238,303,465   $ 575     (11,613,685) 11,613,110
Balance (in Shares) at Sep. 30, 2022 23,000,000   5,750,000        
Balance at Dec. 31, 2021   $ 575   24,425 (49,868) (24,868)
Balance (in Shares) at Dec. 31, 2021   5,750,000        
Accretion of Class A ordinary shares to redemption value   (27,928,643)         (27,928,643)
Balance at Dec. 31, 2022 $ 240,311,986   $ 575   (9,446,841) (9,446,266)
Balance (in Shares) at Dec. 31, 2022 23,000,000   5,750,000        
Balance at Mar. 31, 2022 $ 236,866,876   $ 575   (16,087,616) (16,087,041)
Balance (in Shares) at Mar. 31, 2022 23,000,000   5,750,000        
Accretion of Class A ordinary shares to redemption value $ 334,734     (334,734) (334,734)
Net income (loss)     6,349,203 6,349,203
Balance at Jun. 30, 2022 $ 237,201,610   $ 575   (10,073,147) (10,072,572)
Balance (in Shares) at Jun. 30, 2022 23,000,000   5,750,000        
Accretion of Class A ordinary shares to redemption value $ 1,101,855         (1,101,855) (1,101,855)
Net income (loss)   (130,575)   (308,108)   (438,683) (438,683)
Balance at Sep. 30, 2022 $ 238,303,465   $ 575     (11,613,685) 11,613,110
Balance (in Shares) at Sep. 30, 2022 23,000,000   5,750,000        
Balance at Dec. 31, 2022 $ 240,311,986   $ 575   (9,446,841) (9,446,266)
Balance (in Shares) at Dec. 31, 2022 23,000,000   5,750,000        
Accretion of Class A ordinary shares to redemption value $ 2,569,175     (2,569,175) (2,569,175)
Net income (loss)     2,278,938 2,278,938
Balance at Mar. 31, 2023 $ 242,881,161   $ 575   (9,737,078) (9,736,503)
Balance (in Shares) at Mar. 31, 2023 23,000,000   5,750,000        
Balance at Dec. 31, 2022 $ 240,311,986   $ 575   (9,446,841) (9,446,266)
Balance (in Shares) at Dec. 31, 2022 23,000,000   5,750,000        
Deferred underwriting fees payable             8,050,000
Net income (loss)   7,748,595   (295,264)     7,453,331
Balance at Sep. 30, 2023 $ 183,950,121   $ 575     (10,795,392) (10,794,817)
Balance (in Shares) at Sep. 30, 2023 16,880,481   5,750,000        
Balance at Mar. 31, 2023 $ 242,881,161   $ 575   (9,737,078) (9,736,503)
Balance (in Shares) at Mar. 31, 2023 23,000,000   5,750,000        
Redemption of Class A ordinary shares $ (65,163,747)    
Redemption of Class A ordinary shares (in Shares) (6,119,519)          
Accretion of Class A ordinary shares to redemption value $ 2,971,830     (2,971,830) (2,971,830)
Net income (loss)     3,408,179 3,408,179
Balance at Jun. 30, 2023 $ 180,689,244   $ 575   (9,300,729) (9,300,154)
Balance (in Shares) at Jun. 30, 2023 16,880,481   5,750,000        
Accretion of Class A ordinary shares to redemption value $ 3,260,877         (3,260,877) (3,260,877)
Net income (loss)   $ 2,145,981   $ (379,767)   1,766,214 1,766,214
Balance at Sep. 30, 2023 $ 183,950,121   $ 575     $ (10,795,392) $ (10,794,817)
Balance (in Shares) at Sep. 30, 2023 16,880,481   5,750,000        
v3.23.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities    
Net income $ 7,453,331 $ 5,080,880
Adjustments to reconcile net income to net cash used in operating activities:    
Realized gain on investments held in Trust Account (7,601,882) (1,403,465)
Transaction costs allocated to derivative warrant liabilities 314,508
Change in fair value of derivative warrant liabilities (780,000) (4,720,500)
Changes in operating assets and liabilities:    
Prepaid expenses 173,901 (373,145)
Accounts payable 226,158
Accrued expenses 6,130 44,281
Net cash used in operating activities (522,362) (1,057,441)
Cash Flows from Investing Activities    
Investment of cash into Trust Account (236,900,000)
Proceeds from redemption of marketable securities held in Trust account 65,163,747
Purchase of U.S. government treasury obligations (672,783,585) (475,200,000)
Trust Account Withdrawal - tax payment  
Proceeds from redemption of U.S. government treasury obligations 671,583,585 475,200,000
Purchase of U.S. government treasury obligations
Net cash provided by (used in) investing activities 63,963,747 (236,900,000)
Cash Flows from Financing Activities    
Redemption of Class A ordinary shares subject to possible redemption (65,163,747)
Proceeds from note payable and advances from related party 1,200,000
Repayment of note payable (3,144) (437,507)
Repayment of amount due to related party (147,190)
Proceeds from sale of Class A ordinary shares, gross subject to possible redemption 230,000,000
Proceeds from sale of Private Placement Warrants 14,500,000
Offering costs paid (5,151,744)
Net cash used in (provided by) financing activities (63,966,891) 238,763,559
Net (decrease) increase in cash (525,506) 806,118
Cash - beginning of period 707,749 440
Cash - end of period 182,243 806,558
Supplemental disclosure of noncash investing and financing activities:    
Initial class A shares subject to possible redemption 212,383,343
Accretion of Class A shares to redemption value 8,801,882 25,920,122
Offering costs included in accrued expenses 211,141
Offering costs paid through promissory note - related party 150,333
Deferred underwriting fees payable $ 8,050,000
v3.23.3
Description of Organization, Business Operations, Liquidity and Going Concern Considerations
9 Months Ended
Sep. 30, 2023
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Abstract]  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations

Note 1 – Description of Organization, Business Operations, Liquidity and Going Concern Considerations

 

Patria Latin American Opportunity Acquisition Corp. (the “Company”) is a blank check company incorporated in Cayman Islands on February 25, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, ordinary shares purchase, reorganization, or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

As of September 30, 2023, the Company had not commenced any operations. All activities for the period from February 25, 2021 (inception), through September 30, 2023, relates to the Company’s formation, and the initial public offering (“IPO”) described below, and post-IPO expenses. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of realized and unrealized gains on investments from the proceeds derived from the IPO.

 

On March 14, 2022, the Company consummated its IPO of 23,000,000 units (the “Units”), including the issuance of 3,000,000 Units as a result of the underwriter’s exercise in full of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one redeemable warrant of the Company (each whole warrant, a “Public Warrant”), with each Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.

 

The Company’s sponsor is Patria SPAC LLC, a Cayman Islands exempted limited partnership (the “Sponsor”). Simultaneously with the closing of the IPO and pursuant to the private placement warrants purchase agreement, the Company completed the private sale of 14,500,000 warrants (the “Private Placement Warrants” and together with the Public Warrants, the “Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $14,500,000.

 

Transaction costs amounted to $13,779,665, including $8,050,000 in deferred underwriting fees payable, $4,600,000 in underwriting fees paid and $1,129,665 in other offering costs, of which $314,508 were expensed and $13,456,157 charged to temporary equity.

 

Following the closing of the IPO on March 14, 2022, an amount of $236,900,000 ($10.30 per Unit) of the proceeds from the IPO and the sale of the Private Placement Warrants, comprised of $225,400,000 of the proceeds from the IPO (which is net of $4,600,000 of the underwriter’s fees) and $11,500,000 of the proceeds of the sale of Private Placement Warrants, was placed in a U.S.-based trust account (the “Trust Account”) at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee. The funds in the Trust Account were invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to earnings on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account until the earliest of: (i) the completion of the Initial Business Combination; (ii) the redemption of the Class A Ordinary Shares included in the Units (the “Public Shares”) if the Company is unable to complete the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus); or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of the Company’s obligation to allow redemption in connection with the Initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated the Initial Business Combination by 15 months after the closing of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in accordance with the terms described in the Company’s final prospectus) or (B) with respect to any other material provisions relating to shareholders’ rights or pre-Initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses.

 

On June 12, 2023, the Company held an extraordinary general meeting of the Company’s shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting, the Company’s shareholders approved amendments to the Company’s Amended and Restated Memorandum and Articles of Association to extend the date (the “Termination Date”) by which the Company has to consummate an initial business combination from June 14, 2023 (the “Original Termination Date”) to June 14, 2024 (the “Articles Extension Date”), in addition to other proposals. Accordingly, the Company now has up to June 14, 2024 to consummate its initial business combination. In connection with the Extraordinary General Meeting, shareholders holding an aggregate of 6,119,519 of the Company’s Class A ordinary shares exercised their right to redeem their shares on June 14, 2023. Following such redemptions, 16,880,481 ordinary shares remained outstanding and subject to redemption. The Trust Account has a remainder balance of $180 million following the withdrawal for Class A ordinary shares redemption. The Company also deposited into the Trust Account an aggregate of $300,000 in order to effect the extension of the termination date for an additional one-month period, from June 14, 2023 to July 14, 2023. The purpose of the extension is to provide time for the Company to complete a business combination. The Company made additional deposits of $300,000 into the Trust account on July 12, 2023, August 12, 2023, and September 13, 2023, in connection with extensions from July 14, 2023 through October 14, 2023. The Company will continue to deposit $300,000 into the Trust Account each month until the earlier of the completion of a Business Combination or liquidation date. On October 10, 2023, the Company made additional deposit of $300,000 representing extension payment through November 14, 2023. On November 13, 2023, the Company made additional deposit of $300,000 representing extension payment through December 14, 2023.

 

Initial Business Combination

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commission held in Trust and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company only intends to complete a Business Combination if the post-business combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the IPO, management has agreed that an amount equal to at least $10.30 per Unit sold in the IPO, including the proceeds from the sale of the Private Placement Warrants, was held in a Trust Account located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company provides the holders (the “Public Shareholders”) of the Company’s issued and outstanding Class A Ordinary Shares, par value $0.0001 per share, sold in the IPO (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Public Shares for a pro rata portion of the amount then held in the Trust Account. The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. If the Company seeks shareholder approval, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Articles of Association (the “Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below) and any Public Shares purchased during or after the IPO in favor of a Business Combination. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

 

The Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The holders of the Founder Shares (the “initial shareholders”) have agreed not to propose an amendment to the Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

 

If the Company is unable to complete a Business Combination by 27 months after the closing of our IPO on March 14, 2022 of the IPO (the “Combination Period”) and the Company’s shareholders have not amended the Articles of Association to extend such Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman law to provide for claims of creditors and the requirements of other applicable law.

 

The initial shareholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares after the IPO, they will be entitled to liquidating distributions from the Trust if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.30. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.30 per unit or (ii) the lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Liquidity and Going Concern Consideration

 

As of September 30, 2023, the Company had working capital of $173,155,304. Of the net proceeds from the IPO and associated sale of Private Placement Warrants, $236,900,000 of cash was placed in the Trust Account. The working capital surplus includes the amount of restricted marketable securities held in the Trust Account, deferred underwriting fees payable and derivative warrant liabilities, all of which have been classified as current at September 30, 2023 as a result of the Company being less than 12 months away from consuming the assets held in the Trust Account to either consummate a business combination or to liquidate. Working capital would be $(1,184,817) if the line items described above were not included in the working capital calculation. Cash of $182,243 was held outside of the Trust Account and is available for the Company’s working capital purposes as of September 30, 2023.

 

The Company anticipates that the cash held outside of the Trust Account as of September 30, 2023 will not be sufficient to allow the Company to operate for at least the next 12 months from the issuance of this unaudited condensed financial statements, assuming that a Business Combination is not consummated during that time. Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued. Management plans to address this uncertainty through the Business Combination as discussed above. In addition, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required under the Working Capital Loans. There is no assurance that the Company’s plans to consummate the Business Combination will be successful or successful within the Combination Period or that the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors will loan the Company funds as may be required under the Working Capital Loans.

 

These unaudited condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Risks and Uncertainties

 

Global economic conditions have been worsening, with disruptions to, and volatility in, the credit and financial markets and rising inflation and interest rates in the U.S. If these conditions persist and deepen, the Company could experience an inability to access additional capital, or our liquidity could otherwise be impacted. Management continues to evaluate the impact related to rising interest rates and current market condition and has concluded while it is reasonably possible that these factors could have a negative effect on the Company’s financial position and results of its operations, the specific impact is not readily determinable as of the date of the unaudited condensed financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

The credit and financial markets have experienced extreme volatility and disruptions due to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia, which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our ordinary shares to be adversely affected.

v3.23.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the periods presented.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of this unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $182,243 and $707,749 in cash outside of the funds held in the Trust Account, as of September 30, 2023 and December 31, 2022, respectively. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.

 

Investments Held in Trust Account

 

The assets held in the Trust Account were held in U.S. government treasury obligations with maturities of 185 days or less, which were invested in U.S. Treasury securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these securities is included in realized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations.

 

Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Accounting Standards Codification (“ASC”) 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet. The Company’s derivative financial instruments are accounted for as liabilities, and the derivative instrument is recorded at its fair value on the issuance date and is then re-valued at each reporting date. The fair value of the Company’s derivative financial instruments is evaluated at the end of each reporting period, with changes in the fair value reported in the unaudited condensed statements of operations. The Company had no other financial assets or liabilities that were required to be measured at fair value on a recurring basis.

 

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

 

Level 2 – Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets of liabilities, that are observable, or (iv) inputs that are derived principally from or corroborated by market data through correlation or other means.

 

Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

Net Income (Loss) per Ordinary Share

 

The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary share outstanding during the period. The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. For the three and nine months ended September 30, 2023, the Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placements to purchase Class A Ordinary Shares in the calculation of diluted income (loss) per share, since their inclusion is contingent on a future event. For the three and nine months ended September 30, 2022 their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

 

A reconciliation of the income (loss) per share is below:

 

   For The Three
Months
Ended
September 30,
2023
   For The Three
Months
Ended
September 30,
2022
 
Net income (loss)  $1,766,214   $(438,683)
Accretion of temporary equity in excess of fair value   (3,260,877)   (1,101,855)
Net income (loss) including accretion of temporary equity in excess of fair value  $(1,494,663)  $(1,540,538)

 

   For The Nine
Months
Ended
September 30,
2023
   For The Nine
Months
Ended
September 30,
2022
 
Net income (loss)  $7,453,331   $5,080,880 
Accretion of temporary equity in excess of fair value   (8,801,882)   (25,920,122)
Net income (loss) including accretion of temporary equity in excess of fair value  $(1,348,551)  $(20,839,242)

 

The Company’s unaudited condensed statements of operations include a presentation of income (loss) per share for shares of ordinary shares subject to possible redemption in a manner similar to the two-class method of earnings per share. With respect to the accretion of the Class A Ordinary Shares subject to possible redemption and consistent with ASC 480, “Distinguishing Liabilities from Equity,” in accordance with ASC 480-10-S99-3A, the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net income (loss) per ordinary share.

 

   For The Three Months Ended
September 30, 2023
   For The Three Months Ended
September 30, 2022
 
   Class A - Temporary Equity   Class B   Class A - Temporary Equity   Class B 
Basic and diluted net income (loss) per share                
Numerator                
Allocation of net income (loss) including accretion of temporary equity in excess of fair value  $(1,114,896)  $(379,767)  $(1,232,430)  $(308,108)
Deemed dividend for accretion of temporary equity in excess of fair value   3,260,877    
-
    1,101,855    
-
 
Allocation of net income and deemed dividend  $2,145,981   $(379,767)  $(130,575)  $(308,108)
Denominator                    
Weighted average shares outstanding, basic and diluted
   16,880,481    5,750,000    23,000,000    5,750,000 
                     
Basic and diluted net income (loss) per share
  $0.13   $(0.07)  $(0.01)  $(0.05)

 

   For The Nine Months Ended
September 30, 2023
   For The Nine Months Ended
September 30, 2022
 
   Class A - Temporary Equity   Class B   Class A - Temporary Equity   Class B 
Basic and diluted net income (loss) per share                
Numerator                
Allocation of net income (loss) including accretion of temporary equity in excess of fair value  $(1,053,287)  $(295,264)  $(14,953,478)  $(5,885,764)
Deemed dividend for accretion of temporary equity in excess of fair value   8,801,882    
-
    25,920,122    
-
 
Allocation of net income and deemed dividend  $7,748,595   $(295,264)  $10,966,644   $(5,885,764)
Denominator                    
Weighted average shares outstanding, basic and diluted
   20,511,844    5,750,000    16,934,066    5,552,198 
                     
Basic and diluted net income (loss) per share
  $0.38   $(0.05)  $0.65   $(1.06)

 

Class A Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC 480.

 

Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A Ordinary Shares feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A Ordinary Shares subject to possible redemption are classified as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. Accordingly, as of September 30, 2023, 16,880,481 shares of Class A Ordinary Shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

 

The Class A Ordinary Shares subject to possible redemption are subject to the subsequent measurement guidance in ASC 480-10-S99. Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the ordinary shares is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the ordinary shares subject to possible redemption to their redemption amount (i.e., $10.30 per share) immediately as if the end of the first reporting period after the IPO, March 14, 2022, was the redemption date. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit. For the year ended December 31, 2022, the Company recorded an accretion of $27,928,643 of which $9,275,425 was recorded in additional paid-in capital and $18,653,218 was recorded in accumulated deficit.

 

At September 30, 2023, 16,880,481 ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

 

Gross proceeds  $230,000,000 
Less:     
Class A ordinary shares issuance costs   (13,465,157)
Fair value of Public Warrants at issuance   (4,151,500)
Plus:     
Accretion of carrying value to redemption value   27,928,643 
Class A ordinary shares subject to possible redemption at December 31, 2022  $240,311,986 
Remeasurement of carrying value to redemption value   8,801,882 
Redemption of Class A ordinary shares   (65,163,747)
Class A ordinary shares subject to possible redemption at September 30, 2023  $183,950,121 

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net- cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

Derivative Warrant Liabilities

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss under the caption change in fair value of derivative warrant liabilities on the unaudited condensed statements of operations. The warrants were valued using a Monte Carlo simulation model until the Class A ordinary shares and warrants began trading separately on May 4, 2022. Since May 4, 2022, the Public Warrants have been measured using the listed market price and the Private Placement Warrants have been measured by reference to the trading price of the Public Warrants.

 

The Class A Ordinary Shares and warrants comprising the units began separate trading on the 52nd day following the date of the IPO. No fractional warrants issued upon separation of the units and only whole warrants will trade. Accordingly, unless a multiple of two units is purchased, the number of warrants issuable to you upon separation of the units will be rounded down to the nearest whole number of warrants.

 

Additionally, the units will automatically separate into their component parts and will not be traded after completion of the Initial Business Combination.

 

Share-based Compensation

 

The Company accounts for Founder Shares issued to its independent directors in accordance with SEC Staff Accounting Bulletin 5T and ASC 718, “Compensation-Stock Compensation.” The fair value of the Founder Shares issued in this arrangement was determined using the implied stock price as of the date of Initial Public Offering of the Company’s Class A ordinary shares and the probability of the success of the Business Combination.

 

Offering Costs

 

Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are directly related to the IPO. Upon the completion of the IPO, the offering costs were allocated using the relative fair values of the Company’s Class A Ordinary Shares and its Public Warrants and Private Placement Warrants. The costs allocated to warrants were recognized in other expenses and those related to the Company’s Class A Ordinary Shares were charged against the carrying value of Class A Ordinary Shares. The Company complies with the requirements of the ASC 340-10-S99-1, “Other Assets and Deferred Costs.”

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and 2022, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. U.S. taxation could be imposed if the Company is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time. Additionally, given the nature of the investment income generated from the funds held in the trust account, it is not subject to tax withholdings in the U.S. Moreover, the Company determined that no income tax liability would arise from any other jurisdictions outside of the Cayman Islands. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

 

Recent Accounting Pronouncements

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020- 06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. As a result of ASU 2020 – 06, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost and more convertible preference shares will be accounted for as a single equity instrument measured at its historical cost, as long as no features require bifurcation and recognition as derivatives. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company is evaluating the impact of ASU 2020-06 on its financial statements.

 

The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.

v3.23.3
Initial Public Offering
9 Months Ended
Sep. 30, 2023
Initial Public Offering [Abstract]  
Initial Public Offering

Note 3 – Initial Public Offering

 

Pursuant to the IPO, the Company sold 23,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A Ordinary Share and one-half of one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A Ordinary Shares at an exercise price of $11.50 per whole share.

 

The Company had granted the Underwriters in the IPO (the “Underwriters”) a 45-day option to purchase up to 3,000,000 additional Units to cover over-allotments, which was exercised in full on the IPO date.

 

On June 12, 2023, 6,119,519 Class A ordinary shares were redeemed by the Company’s shareholders in connection with the Extraordinary General Meeting mentioned in Note 1. Following such redemptions, 22,630,481 ordinary shares remained outstanding, consisting of 16,880,481 Class A ordinary shares and 5,750,000 Class B ordinary shares.

v3.23.3
Private Placement Warrants
9 Months Ended
Sep. 30, 2023
Private Placement Warrants [Abstract]  
Private Placement Warrants

Note 4 – Private Placement Warrants

 

Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 14,500,000 of Private Placement Warrants, including the overallotment option, at a price of $1.00 per Private Placement Warrant ($14,500,000 in the aggregate). Each Private Placement Warrant is exercisable to purchase one share of Class A Ordinary Shares at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. Upon the purchase of the Private Placement Warrants by the Sponsor, the Company recorded the excess proceeds received over the fair value of the Private Placement Warrants as additional paid-in capital amounting to $9,251,000.

v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 5 – Related Party Transactions

 

Founder Shares

 

On March 3, 2021, one of our officers paid $25,000, to cover certain of our offering costs, in exchange for an aggregate of 7,187,500 Class B ordinary shares (the “Founder Shares”), which were temporarily issued to such officer until such shares were transferred to our sponsor in April 2021. Our Sponsor was formed on March 9, 2021. In February 2022, our Sponsor forfeited 1,437,500 Founder Shares for no consideration, remaining with 5,750,000 Founder Shares. Prior to the IPO, on March 9, 2022, our Sponsor transferred 30,000 of our Founder Shares to each of our three independent directors. These 90,000 shares were not subject to forfeiture. The allocation of the Founder Shares to the directors is in the scope of ASC 718. Under ASC 718, share-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Company used the Monte Carlo model to estimate the fair value associated with the Founder Shares granted. The fair value of the 90,000 shares granted to the Company’s directors in March 2022 was $662,245 or $7.36 per share. The Founder Shares were granted subject to a performance condition, the occurrence of an Initial Business Combination. Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence under ASC 718. The Company determined the performance conditions are not considered probable, and, therefore, no share-based compensation expense was recognized for period ended September 30, 2023 and 2022. As of September 30, 2023 and 2022, the unrecognized stock compensation expense was $662,245.

 

On March 14, 2022, the underwriters fully exercised the over-allotment option; thus, the 750,000 Founder Shares are no longer subject to forfeiture.

 

The Sponsor has agreed not to transfer, assign or sell any of their founder shares and any Class A Ordinary Shares issued upon conversion thereof until the earlier to occur of (A) one year after the completion of our initial business combination; or (B) subsequent to our initial business combination, (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date following the completion of our initial business combination on which we complete a liquidation, merger, amalgamation, stock exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property.

 

The Founder Shares will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation of the Company’s Initial Business Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A Ordinary Shares or equity-linked securities are issued or deemed issued in connection with the Company’s Initial Business Combination, the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A Ordinary Shares outstanding after such conversion (after giving effect to any redemptions of Class A Ordinary Shares by Public Shareholders), including the total number of Class A Ordinary Shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the Initial Business Combination, excluding any Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary Shares issued, or to be issued, to any seller in the Initial Business Combination and any Private Placement Warrants issued to the Sponsor, or the Company’s officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

 

Promissory Note – Related Party

 

On March 3, 2021, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $250,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) March 31, 2023, and (ii) the completion of the IPO. On January 31, 2022, the Company amended the unsecured Promissory Note to provide an additional borrowing of $250,000, for a total borrowing capacity of $500,000. Promissory note balance as of December 31, 2021 was $437,508 which was fully paid upon the Company’s consummation of its initial public offering. There is no outstanding balance on the promissory note as of March 31, 2023 and December 31, 2022, respectively.

 

Due to Related Party

 

As of September 30, 2023 and December 31, 2022, the Company had an outstanding balance of $1,2000,000 and $3,144 due to the Sponsor related to expenses paid by the Sponsor on behalf of the Company. This amount is due on demand. During the year ended December 31, 2022, the Company borrowed $150,334 from the Sponsor, all of which was repaid except the outstanding balance of $3,144. As of September 30, 2023, the Company has deposited an aggregate of $1,200,000 into the Trust Account in the form of a loan in connection with the extension of the termination date for an additional four-month period, from June 14, 2023 to October 14, 2023. The loan has no interest and is forgiven should the Company not complete an initial business combination. The Sponsor is committed to extending the $300,000 monthly loan to the Company till the earlier of liquidation date or the consummation of an initial business combination. On October 10, 2023, the Company borrowed additional $300,000 from its Sponsor and deposited such into the Trust Account as extension deposit through November 14, 2023. On November 13, 2023, the Company made additional deposit of $300,000 representing extension payment through December 14, 2023.

 

Administrative Services Agreement

 

Following our IPO, the Company pays the Sponsor or an affiliate a monthly fee of $10,000 for office space, utilities, secretarial and administrative services. In August 2023, the Company and its Sponsor executed an agreement to discontinue the remittance of administrative fees to the Sponsor with an effective date of August 1, 2023. For the three and nine months ended September 30, 2023, the Company incurred and paid $0 and $60,000 in administrative support fees, respectively. For the three and nine months ended September 30, 2022, the Company incurred and paid $30,000 and $65,484   in administrative support fees, respectively.

 

Working Capital Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2023 and December 31, 2022, the Company had no borrowings under the Working Capital Loans.

v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

Note 6 – Commitments and Contingencies

 

Registration Rights

 

The holders of Founder Shares and Private Placement Warrants, including any that may be issued upon conversion of Working Capital Loans, if any (and any Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants, including any that may be issued upon conversion of the Working Capital Loans), will be entitled to registration rights pursuant to a registration rights agreement entered into prior to the consummation of the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company is not required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to an additional 3,000,000 Units to cover over-allotments. The underwriter fully exercised its over-allotment option concurrently with the close of the IPO. The underwriter was entitled to a cash underwriting discount of $0.20 per Unit (or $4,600,000) of the gross proceeds of the IPO. Additionally, the underwriter is entitled to a deferred underwriting commission of $0.35 per Unit (or $8,050,000) of the gross proceeds of the IPO upon the completion of the Company’s Initial Business Combination. The deferred underwriting commissions will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement.

v3.23.3
Derivative Warrant Liabilities
9 Months Ended
Sep. 30, 2023
Derivative Warrant Liabilities [Abstract]  
Derivative Warrant Liabilities

Note 7 – Derivative Warrant Liabilities

 

The Company accounted for the 26,000,000 Warrants issued in connection with the IPO (the 11,500,000 of Public Warrants and the 14,500,000 of Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the Warrants do not meet the criteria for equity treatment thereunder, each Warrant much be recorded as a liability. Accordingly, the Company classifies each Warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s unaudited condensed statements of operations.

 

Each whole Warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. Only whole Warrants are exercisable. The Warrants will become exercisable 30 days after the completion of the Initial Business Combination and will expire five years after the completion of the Initial Business Combination or earlier upon redemption or liquidation.

 

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable 30 days after the completion of an Initial Business Combination provided that the Company has an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or holders are permitted to exercise their Public Warrants on a cashless basis under certain circumstances as a result of (i) the Company’s failure to have an effective registration statement by the 60th business day after the closing of the Initial Business Combination or (ii) a notice of redemption described under “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00”). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of its Initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement for the IPO or a new registration statement covering the Class A Ordinary Shares issuable upon exercise of the Warrants and will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the Company’s Initial Business Combination and to maintain a current prospectus relating to those Class A Ordinary Shares until the Warrants expire or are redeemed. If the shares issuable upon exercise of the Public Warrants are not registered under the Securities Act in accordance with the above requirements, the Company will be required to permit holders to exercise their Public Warrants on a cashless basis. However, no Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. Notwithstanding the above, if the Company’s Class A Ordinary Shares are at the time of any exercise of a Public Warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

 

The Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00” and “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

 

The Private Placement Warrants are identical to the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees, (i) they will not be redeemable by the Company, (ii) they (including the Class A Ordinary Shares issuable upon exercise of these Warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Initial Business Combination, (iii) they may be exercised by the holders on a cashless basis, (iv) are subject to registration rights and (v) use a different Black-Scholes Warrant Model for purposes of calculating the Black-Scholes Warrant Value (as defined in the warrant agreement).

 

On the exercise of any Warrant, the Warrant exercise price will be paid directly to us and not placed in the Trust Account.

 

Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except as described herein with respect to the Private Placement Warrants):

 

  in whole and not in part;

 

  at a price of $0.01 per Warrant;

 

  upon a minimum of 30 days’ prior written notice of redemption; and

 

  if, and only if, the last reported sale price of Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

 

The Company will not redeem the Warrants as described above unless an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the Warrants is effective and a current prospectus relating to those Class A Ordinary Shares is available throughout the 30-day redemption period. Any such exercise would not be on a cashless basis and would require the exercising warrant holder to pay the exercise price for each Warrant being exercised.

 

Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants:

 

  in whole and not in part;

 

  at a price of $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth in the warrant agreement based on the redemption date and the “redemption fair market value” of Class A Ordinary Shares (as defined below) except as otherwise described in the warrant agreement;

 

  if, and only if, the closing price of Class A Ordinary Shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and

 

  if the closing price of the Class A Ordinary Shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

 

Solely for the purposes of this redemption provision, the “redemption fair market value” of the Company’s Class A Ordinary Shares shall mean the volume weighted average price of the Class A Ordinary Shares for the ten (10) trading days immediately following the date on which notice of redemption is sent to the holders of Warrants.

 

No fractional Class A Ordinary Shares issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class A Ordinary Shares to be issued to the holder.

v3.23.3
Shareholder's Deficit
9 Months Ended
Sep. 30, 2023
Shareholder’s Deficit [Abstract]  
Shareholder's Deficit

Note 8 – Shareholder’s Deficit

 

Preference Shares The Company is authorized to issue 1,000,000 preference shares, par value $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2023 and December 31, 2022, there were no preference shares issued or outstanding.

 

Class A Ordinary Shares – The Company is authorized to issue 200,000,000 Class A Ordinary Shares with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, there were 16,880,481 and 23,000,000 shares, respectively, of Class A Ordinary Shares issued and outstanding that are subject to possible redemption.

 

Class B Ordinary Shares – The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of September 30, 2023 and December 31, 2022, 5,750,000 Class B ordinary shares were issued and outstanding.

 

Holders of the Class A Ordinary Shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares shall have the right to vote on the appointment and removal of the Company’s directors prior to the Initial Business Combination or continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents of the Company or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands).

v3.23.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2023
Fair Value Measurements [Abstract]  
Fair Value Measurements

Note 9 – Fair Value Measurements

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023.

 

   Level 1   Level 2   Level 3   Total 
Assets                
Marketable securities held in Trust Account  $183,950,121   $
   $
   $183,950,121 
   $183,950,121   $
   $
   $183,950,121 
Liabilities                    
Public Warrants  $690,000   $
   $
   $690,000 
Private Placement Warrants   
    870,000    
    870,000 
Total liabilities  $690,000   $870,000   $
   $1,560,000 

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022, including the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

 

   Level 1   Level 2   Level 3   Total 
Assets                
Investments held in Trust Account  $240,311,986   $
   $
   $240,311,986 
Total assets  $240,311,986   $
   $
   $240,311,986 
                     
Liabilities                    
Public Warrants  $1,035,000   $
   $
   $1,035,000 
Private Placement Warrants  $
   $1,305,000    
    1,305,000 
Total liabilities  $1,035,000   $1,305,000   $
   $2,340,000 

 

The Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting date. Changes in the fair value of the Warrants are recorded in the statements of operations each period.

 

Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. During the quarter ended September 30, 2023 there were no transfers to/from any level. During the year ended December 31, 2022, the public and private warrants were transferred out of level 3 into level 1 and level 2, respectively. See the table below to illustrate the transfers out of level 3.

 

Level 3 warrant liabilities at January 1, 2022  $
 
Addition at March 14, 2022   9,400,500 
Change in fair value of warrant liabilities   (7,060,500)
Transfers from level 3 to level 2 instruments   (1,305,000)
Transfers from level 3 to level 1 instruments   (1,035,000)
Level 3 warrant liabilities at December 31, 2022  $
 

 

The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model. The fair value of Public Warrants issued in connection with the Initial Public Offering was measured based on the listed market price of such warrants, a Level 1 measurement, since May 4, 2022. The fair value of the Private Placement Warrants has subsequently been measured by reference to the trading price of the Public Warrants, which is considered to be a Level 2 fair value measurement. The Company recognized change in the fair value of warrant liabilities of $353,600 and $780,000, which are presented as changes in fair value of derivative warrant liabilities on the accompanying unaudited condensed statements of operations for the three and nine months ended September 30, 2023, respectively. The Company recognized a change in the fair value of warrant liabilities of $7,060,500, which is presented as change in fair value of derivative warrant liabilities on the statements of operations for the year ended December 31, 2022.

 

The following table provides quantitative information regarding Level 3 fair value measurement inputs for the Public Warrants and Private Placement Warrants at their measurement date:

 

   March 14,
2022
 
   (IPO date) 
Exercise Price  $11.50 
Underlying share price  $9.82 
Volatility   5.4%
Term to Business Combination (years)   6.05 
Risk-free rate   2.13%

 

The table below shows the change in fair value of the derivative warrant liabilities as of September 30, 2023:

 

   Private
Warrant
   Public
Warrant
   Total 
Fair value at January 1, 2023  $1,305,000   $1,035,000   $2,340,000 
Change in fair value   (435,000)   
(345,00
)   (780,000)
Fair value as of September 30, 2023  $870,000   $690,000   $1,560,000 

 

The table below shows the change in fair value of the derivative warrant liabilities as of September 30, 2022:

 

   Private
Warrant
   Public
Warrant
   Total 
Fair value at January 1, 2022  $
   $
   $
 
Fair value at March 14, 2022   4,151,500    5,249,000    9,400,500 
Change in fair value   2,081,500    2,639,000    4,720,500 
Fair value as of September 30, 2022  $2,070,000   $2,610,000   $4,680,000 
v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for the periods presented.

Emerging Growth Company

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

Use of Estimates

The preparation of this unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $182,243 and $707,749 in cash outside of the funds held in the Trust Account, as of September 30, 2023 and December 31, 2022, respectively. The Company did not have any cash equivalents as of September 30, 2023 and December 31, 2022.

Investments Held in Trust Account

Investments Held in Trust Account

The assets held in the Trust Account were held in U.S. government treasury obligations with maturities of 185 days or less, which were invested in U.S. Treasury securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these securities is included in realized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations.

Financial Instruments

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under Accounting Standards Codification (“ASC”) 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet. The Company’s derivative financial instruments are accounted for as liabilities, and the derivative instrument is recorded at its fair value on the issuance date and is then re-valued at each reporting date. The fair value of the Company’s derivative financial instruments is evaluated at the end of each reporting period, with changes in the fair value reported in the unaudited condensed statements of operations. The Company had no other financial assets or liabilities that were required to be measured at fair value on a recurring basis.

Fair Value Measurements

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.

Level 2 – Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets of liabilities, that are observable, or (iv) inputs that are derived principally from or corroborated by market data through correlation or other means.

Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

Net Income (Loss) per Ordinary Share

Net Income (Loss) per Ordinary Share

The Company complies with accounting and disclosure requirements of ASC 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary share outstanding during the period. The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. For the three and nine months ended September 30, 2023, the Company has not considered the effect of the warrants sold in the Initial Public Offering and Private Placements to purchase Class A Ordinary Shares in the calculation of diluted income (loss) per share, since their inclusion is contingent on a future event. For the three and nine months ended September 30, 2022 their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.

 

A reconciliation of the income (loss) per share is below:

   For The Three
Months
Ended
September 30,
2023
   For The Three
Months
Ended
September 30,
2022
 
Net income (loss)  $1,766,214   $(438,683)
Accretion of temporary equity in excess of fair value   (3,260,877)   (1,101,855)
Net income (loss) including accretion of temporary equity in excess of fair value  $(1,494,663)  $(1,540,538)
   For The Nine
Months
Ended
September 30,
2023
   For The Nine
Months
Ended
September 30,
2022
 
Net income (loss)  $7,453,331   $5,080,880 
Accretion of temporary equity in excess of fair value   (8,801,882)   (25,920,122)
Net income (loss) including accretion of temporary equity in excess of fair value  $(1,348,551)  $(20,839,242)

The Company’s unaudited condensed statements of operations include a presentation of income (loss) per share for shares of ordinary shares subject to possible redemption in a manner similar to the two-class method of earnings per share. With respect to the accretion of the Class A Ordinary Shares subject to possible redemption and consistent with ASC 480, “Distinguishing Liabilities from Equity,” in accordance with ASC 480-10-S99-3A, the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net income (loss) per ordinary share.

   For The Three Months Ended
September 30, 2023
   For The Three Months Ended
September 30, 2022
 
   Class A - Temporary Equity   Class B   Class A - Temporary Equity   Class B 
Basic and diluted net income (loss) per share                
Numerator                
Allocation of net income (loss) including accretion of temporary equity in excess of fair value  $(1,114,896)  $(379,767)  $(1,232,430)  $(308,108)
Deemed dividend for accretion of temporary equity in excess of fair value   3,260,877    
-
    1,101,855    
-
 
Allocation of net income and deemed dividend  $2,145,981   $(379,767)  $(130,575)  $(308,108)
Denominator                    
Weighted average shares outstanding, basic and diluted
   16,880,481    5,750,000    23,000,000    5,750,000 
                     
Basic and diluted net income (loss) per share
  $0.13   $(0.07)  $(0.01)  $(0.05)
   For The Nine Months Ended
September 30, 2023
   For The Nine Months Ended
September 30, 2022
 
   Class A - Temporary Equity   Class B   Class A - Temporary Equity   Class B 
Basic and diluted net income (loss) per share                
Numerator                
Allocation of net income (loss) including accretion of temporary equity in excess of fair value  $(1,053,287)  $(295,264)  $(14,953,478)  $(5,885,764)
Deemed dividend for accretion of temporary equity in excess of fair value   8,801,882    
-
    25,920,122    
-
 
Allocation of net income and deemed dividend  $7,748,595   $(295,264)  $10,966,644   $(5,885,764)
Denominator                    
Weighted average shares outstanding, basic and diluted
   20,511,844    5,750,000    16,934,066    5,552,198 
                     
Basic and diluted net income (loss) per share
  $0.38   $(0.05)  $0.65   $(1.06)

 

Class A Ordinary Shares Subject to Possible Redemption

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A Ordinary Shares subject to possible redemption in accordance with the guidance in ASC 480.

Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A Ordinary Shares feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, Class A Ordinary Shares subject to possible redemption are classified as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheets. Accordingly, as of September 30, 2023, 16,880,481 shares of Class A Ordinary Shares subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

The Class A Ordinary Shares subject to possible redemption are subject to the subsequent measurement guidance in ASC 480-10-S99. Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the ordinary shares is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the ordinary shares subject to possible redemption to their redemption amount (i.e., $10.30 per share) immediately as if the end of the first reporting period after the IPO, March 14, 2022, was the redemption date. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit. For the year ended December 31, 2022, the Company recorded an accretion of $27,928,643 of which $9,275,425 was recorded in additional paid-in capital and $18,653,218 was recorded in accumulated deficit.

At September 30, 2023, 16,880,481 ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.

Gross proceeds  $230,000,000 
Less:     
Class A ordinary shares issuance costs   (13,465,157)
Fair value of Public Warrants at issuance   (4,151,500)
Plus:     
Accretion of carrying value to redemption value   27,928,643 
Class A ordinary shares subject to possible redemption at December 31, 2022  $240,311,986 
Remeasurement of carrying value to redemption value   8,801,882 
Redemption of Class A ordinary shares   (65,163,747)
Class A ordinary shares subject to possible redemption at September 30, 2023  $183,950,121 
Derivative Financial Instruments

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net- cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.

 

Derivative Warrant Liabilities

Derivative Warrant Liabilities

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss under the caption change in fair value of derivative warrant liabilities on the unaudited condensed statements of operations. The warrants were valued using a Monte Carlo simulation model until the Class A ordinary shares and warrants began trading separately on May 4, 2022. Since May 4, 2022, the Public Warrants have been measured using the listed market price and the Private Placement Warrants have been measured by reference to the trading price of the Public Warrants.

The Class A Ordinary Shares and warrants comprising the units began separate trading on the 52nd day following the date of the IPO. No fractional warrants issued upon separation of the units and only whole warrants will trade. Accordingly, unless a multiple of two units is purchased, the number of warrants issuable to you upon separation of the units will be rounded down to the nearest whole number of warrants.

Additionally, the units will automatically separate into their component parts and will not be traded after completion of the Initial Business Combination.

Share-based Compensation

Share-based Compensation

The Company accounts for Founder Shares issued to its independent directors in accordance with SEC Staff Accounting Bulletin 5T and ASC 718, “Compensation-Stock Compensation.” The fair value of the Founder Shares issued in this arrangement was determined using the implied stock price as of the date of Initial Public Offering of the Company’s Class A ordinary shares and the probability of the success of the Business Combination.

Offering Costs

Offering Costs

Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are directly related to the IPO. Upon the completion of the IPO, the offering costs were allocated using the relative fair values of the Company’s Class A Ordinary Shares and its Public Warrants and Private Placement Warrants. The costs allocated to warrants were recognized in other expenses and those related to the Company’s Class A Ordinary Shares were charged against the carrying value of Class A Ordinary Shares. The Company complies with the requirements of the ASC 340-10-S99-1, “Other Assets and Deferred Costs.”

Income Taxes

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and 2022, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. U.S. taxation could be imposed if the Company is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a U.S. trade or business at this time. Additionally, given the nature of the investment income generated from the funds held in the trust account, it is not subject to tax withholdings in the U.S. Moreover, the Company determined that no income tax liability would arise from any other jurisdictions outside of the Cayman Islands. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.

Concentration of Credit Risk

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020- 06”), which simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. As a result of ASU 2020 – 06, more convertible debt instruments will be accounted for as a single liability measured at its amortized cost and more convertible preference shares will be accounted for as a single equity instrument measured at its historical cost, as long as no features require bifurcation and recognition as derivatives. The amendments are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company is evaluating the impact of ASU 2020-06 on its financial statements.

The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.

v3.23.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of Reconciliation of the Income (Loss) Per Share A reconciliation of the income (loss) per share is below:
   For The Three
Months
Ended
September 30,
2023
   For The Three
Months
Ended
September 30,
2022
 
Net income (loss)  $1,766,214   $(438,683)
Accretion of temporary equity in excess of fair value   (3,260,877)   (1,101,855)
Net income (loss) including accretion of temporary equity in excess of fair value  $(1,494,663)  $(1,540,538)
   For The Nine
Months
Ended
September 30,
2023
   For The Nine
Months
Ended
September 30,
2022
 
Net income (loss)  $7,453,331   $5,080,880 
Accretion of temporary equity in excess of fair value   (8,801,882)   (25,920,122)
Net income (loss) including accretion of temporary equity in excess of fair value  $(1,348,551)  $(20,839,242)
Schedule of Company’s Unaudited Condensed Statements of Operations Include a Presentation of Income (Loss) the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net income (loss) per ordinary share.
   For The Three Months Ended
September 30, 2023
   For The Three Months Ended
September 30, 2022
 
   Class A - Temporary Equity   Class B   Class A - Temporary Equity   Class B 
Basic and diluted net income (loss) per share                
Numerator                
Allocation of net income (loss) including accretion of temporary equity in excess of fair value  $(1,114,896)  $(379,767)  $(1,232,430)  $(308,108)
Deemed dividend for accretion of temporary equity in excess of fair value   3,260,877    
-
    1,101,855    
-
 
Allocation of net income and deemed dividend  $2,145,981   $(379,767)  $(130,575)  $(308,108)
Denominator                    
Weighted average shares outstanding, basic and diluted
   16,880,481    5,750,000    23,000,000    5,750,000 
                     
Basic and diluted net income (loss) per share
  $0.13   $(0.07)  $(0.01)  $(0.05)
   For The Nine Months Ended
September 30, 2023
   For The Nine Months Ended
September 30, 2022
 
   Class A - Temporary Equity   Class B   Class A - Temporary Equity   Class B 
Basic and diluted net income (loss) per share                
Numerator                
Allocation of net income (loss) including accretion of temporary equity in excess of fair value  $(1,053,287)  $(295,264)  $(14,953,478)  $(5,885,764)
Deemed dividend for accretion of temporary equity in excess of fair value   8,801,882    
-
    25,920,122    
-
 
Allocation of net income and deemed dividend  $7,748,595   $(295,264)  $10,966,644   $(5,885,764)
Denominator                    
Weighted average shares outstanding, basic and diluted
   20,511,844    5,750,000    16,934,066    5,552,198 
                     
Basic and diluted net income (loss) per share
  $0.38   $(0.05)  $0.65   $(1.06)

 

Schedule of Ordinary Shares Subject to Possible Redemption At September 30, 2023, 16,880,481 ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
Gross proceeds  $230,000,000 
Less:     
Class A ordinary shares issuance costs   (13,465,157)
Fair value of Public Warrants at issuance   (4,151,500)
Plus:     
Accretion of carrying value to redemption value   27,928,643 
Class A ordinary shares subject to possible redemption at December 31, 2022  $240,311,986 
Remeasurement of carrying value to redemption value   8,801,882 
Redemption of Class A ordinary shares   (65,163,747)
Class A ordinary shares subject to possible redemption at September 30, 2023  $183,950,121 
v3.23.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Measurements [Abstract]  
Schedule of Company’s Assets and Liabilities are Measured at Fair Value on a Recurring Basis The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023.
   Level 1   Level 2   Level 3   Total 
Assets                
Marketable securities held in Trust Account  $183,950,121   $
   $
   $183,950,121 
   $183,950,121   $
   $
   $183,950,121 
Liabilities                    
Public Warrants  $690,000   $
   $
   $690,000 
Private Placement Warrants   
    870,000    
    870,000 
Total liabilities  $690,000   $870,000   $
   $1,560,000 
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022, including the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
   Level 1   Level 2   Level 3   Total 
Assets                
Investments held in Trust Account  $240,311,986   $
   $
   $240,311,986 
Total assets  $240,311,986   $
   $
   $240,311,986 
                     
Liabilities                    
Public Warrants  $1,035,000   $
   $
   $1,035,000 
Private Placement Warrants  $
   $1,305,000    
    1,305,000 
Total liabilities  $1,035,000   $1,305,000   $
   $2,340,000 
Schedule of Public and Private Warrants Were Transferred Out of Level 3 into Level 1 and Level 2 Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. During the quarter ended September 30, 2023 there were no transfers to/from any level. During the year ended December 31, 2022, the public and private warrants were transferred out of level 3 into level 1 and level 2, respectively. See the table below to illustrate the transfers out of level 3.
Level 3 warrant liabilities at January 1, 2022  $
 
Addition at March 14, 2022   9,400,500 
Change in fair value of warrant liabilities   (7,060,500)
Transfers from level 3 to level 2 instruments   (1,305,000)
Transfers from level 3 to level 1 instruments   (1,035,000)
Level 3 warrant liabilities at December 31, 2022  $
 
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Inputs for the Public Warrants and Private Placement Warrants The following table provides quantitative information regarding Level 3 fair value measurement inputs for the Public Warrants and Private Placement Warrants at their measurement date:
   March 14,
2022
 
   (IPO date) 
Exercise Price  $11.50 
Underlying share price  $9.82 
Volatility   5.4%
Term to Business Combination (years)   6.05 
Risk-free rate   2.13%
Schedule of Change in Fair Value of the Derivative Warrant Liabilities The table below shows the change in fair value of the derivative warrant liabilities as of September 30, 2023:
   Private
Warrant
   Public
Warrant
   Total 
Fair value at January 1, 2023  $1,305,000   $1,035,000   $2,340,000 
Change in fair value   (435,000)   
(345,00
)   (780,000)
Fair value as of September 30, 2023  $870,000   $690,000   $1,560,000 
The table below shows the change in fair value of the derivative warrant liabilities as of September 30, 2022:
   Private
Warrant
   Public
Warrant
   Total 
Fair value at January 1, 2022  $
   $
   $
 
Fair value at March 14, 2022   4,151,500    5,249,000    9,400,500 
Change in fair value   2,081,500    2,639,000    4,720,500 
Fair value as of September 30, 2022  $2,070,000   $2,610,000   $4,680,000 
v3.23.3
Description of Organization, Business Operations, Liquidity and Going Concern Considerations (Details) - USD ($)
3 Months Ended 9 Months Ended
Nov. 13, 2023
Oct. 10, 2023
Jul. 12, 2023
Jun. 14, 2023
Mar. 14, 2022
Jun. 30, 2023
Mar. 31, 2022
Sep. 30, 2023
Dec. 31, 2022
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Shares issued (in Shares)         236,900,000        
Price, per unit (in Dollars per share)         $ 10        
Transaction costs               $ 13,779,665  
Deferred underwriting fees payable             8,050,000  
Underwriting commissions               4,600,000  
Other offering costs               1,129,665  
Other cost expensed               314,508  
Charged to temporary equity               $ 13,456,157  
Ordinary shares exercised                
Outstanding shares (in Shares)               16,880,481  
Trust account balance               $ 180,000,000  
Aggregate amount               300,000  
Additional deposits value     $ 300,000            
Trust account deposit               $ 300,000  
Fair market value percentage               80.00%  
Per share value (in Dollars per share)               $ 10.3  
Aggregate public share percentage               15.00%  
Public shares redeem percentage               100.00%  
Interest to pay dissolution expenses               $ 100,000  
Working capital amount               (1,184,817)  
Net proceeds               236,900,000  
Cash held in trust account               $ 182,243  
IPO [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Shares issued (in Shares)         23,000,000     23,000,000  
Price, per share (in Dollars per share)         $ 10.3        
Price, per unit (in Dollars per share)               $ 10  
IPO amount         $ 225,400,000        
Deferred underwriting fees         $ 4,600,000        
Per share value (in Dollars per share)               $ 10.3  
Working capital amount               $ 173,155,304  
Over-Allotment Option [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Shares issued (in Shares)         3,000,000        
Private Placement Warrants [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Price, per share (in Dollars per share)               $ 1  
Gross proceeds               $ 14,500,000  
Sale of warrants (in Shares)               14,500,000  
Warrants issued         $ 11,500,000        
Class A Ordinary Shares [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Common stock, par value (in Dollars per share)               $ 0.0001 $ 0.0001
Price, per share (in Dollars per share)         $ 11.5        
Gross proceeds         $ 230,000,000        
Ordinary shares exercised       $ 6,119,519          
Outstanding shares (in Shares)               16,880,481 23,000,000
Class A Ordinary Shares [Member] | IPO [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Common stock, par value (in Dollars per share)         $ 0.0001        
Subsequent Event [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Additional deposits value $ 300,000 $ 300,000              
Trust Account [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Per share value (in Dollars per share)               $ 10.3  
Business Combination [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Public shares percentage               100.00%  
Initial Business Combination [Member]                  
Description of Organization, Business Operations, Liquidity and Going Concern Considerations [Line Items]                  
Business combination acquires percentage               50.00%  
v3.23.3
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2022
Summary of Significant Accounting Policies [Line Items]              
Cash and cash equivalents $ 182,243           $ 707,749
Class A ordinary shares subject to possible redemption (in Shares) 16,880,481           23,000,000
Price per share (in Dollars per share) $ 10            
Acceration redemption value $ 3,260,877 $ 2,971,830 $ 2,569,175 $ 1,101,855 $ 334,734 $ 24,483,533 $ 27,928,643
Additional paid in capital             9,275,425
Accumulated deficit             $ 18,653,218
IPO [Member]              
Summary of Significant Accounting Policies [Line Items]              
Redemption per share (in Dollars per share) $ 10.3            
Class A Ordinary Shares [Member]              
Summary of Significant Accounting Policies [Line Items]              
Class A ordinary shares subject to possible redemption (in Shares) 16,880,481           23,000,000
Acceration redemption value             $ 27,928,643
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Reconciliation of the Income (Loss) Per Share - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Schedule Of Reconciliation Of The Income Loss Per Share [Abstract]                
Net income (loss) $ 1,766,214 $ 3,408,179 $ 2,278,938 $ (438,683) $ 6,349,203 $ (829,640) $ 7,453,331 $ 5,080,880
Accretion of temporary equity in excess of fair value (3,260,877)     (1,101,855)     (8,801,882) (25,920,122)
Net income including accretion of temporary equity in excess of fair value $ (1,494,663)     $ (1,540,538)     $ (1,348,551) $ (20,839,242)
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Company’s Unaudited Condensed Statements of Operations Include a Presentation of Income (Loss) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A - Temporary Equity [Member]        
Numerator        
Allocation of net income including accretion of temporary equity in excess of fair value $ (1,114,896) $ (1,232,430) $ (1,053,287) $ (14,953,478)
Deemed dividend for accretion of temporary equity in excess of fair value 3,260,877 1,101,855 8,801,882 25,920,122
Allocation of net income and deemed dividend $ 2,145,981 $ (130,575) $ 7,748,595 $ 10,966,644
Denominator        
Weighted average shares outstanding, basic (in Shares) 16,880,481 23,000,000 20,511,844 16,934,066
Basic net income per share (in Dollars per share) $ 0.13 $ (0.01) $ 0.38 $ 0.65
Class B - Temporary Equity [Member]        
Numerator        
Allocation of net income including accretion of temporary equity in excess of fair value $ (379,767) $ (308,108) $ (295,264) $ (5,885,764)
Deemed dividend for accretion of temporary equity in excess of fair value
Allocation of net income and deemed dividend $ (379,767) $ (308,108) $ (295,264) $ (5,885,764)
Denominator        
Weighted average shares outstanding, basic (in Shares) 5,750,000 5,750,000 5,750,000 5,552,198
Basic net income per share (in Dollars per share) $ (0.07) $ (0.05) $ (0.05) $ (1.06)
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Company’s Unaudited Condensed Statements of Operations Include a Presentation of Income (Loss) (Parentheticals) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Class A - Temporary Equity [Member]        
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]        
Weighted average shares outstanding, diluted 16,880,481 23,000,000 20,511,844 16,934,066
Diluted net income per share $ 0.13 $ (0.01) $ 0.38 $ 0.65
Class B - Temporary Equity [Member]        
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]        
Weighted average shares outstanding, diluted 5,750,000 5,750,000 5,750,000 5,552,198
Diluted net income per share $ (0.07) $ (0.05) $ (0.05) $ (1.06)
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of Ordinary Shares Subject to Possible Redemption - Class A Ordinary Shares [Member] - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Schedule of Ordinary Shares Subject to Possible Redemption [Line Items]    
Gross proceeds   $ 230,000,000
Less:    
Class A ordinary shares issuance costs   (13,465,157)
Fair value of Public Warrants at issuance   (4,151,500)
Plus:    
Accretion of carrying value to redemption value   27,928,643
Class A ordinary shares subject to possible redemption $ 183,950,121 $ 240,311,986
Remeasurement of carrying value to redemption value 8,801,882  
Redemption of Class A ordinary shares $ (65,163,747)  
v3.23.3
Initial Public Offering (Details) - $ / shares
9 Months Ended
Jun. 12, 2023
Mar. 14, 2022
Sep. 30, 2023
Initial Public Offering [Line Items]      
Sold units   236,900,000  
Purchase price per unit (in Dollars per share)   $ 10  
Exercise price per share (in Dollars per share)     $ 11.5
Ordinary shares outstanding 22,630,481    
IPO [Member]      
Initial Public Offering [Line Items]      
Sold units   23,000,000 23,000,000
Purchase price per unit (in Dollars per share)     $ 10
Over-Allotment Option [Member]      
Initial Public Offering [Line Items]      
Sold units   3,000,000  
Sold units     3,000,000
Class A Ordinary Shares [Member]      
Initial Public Offering [Line Items]      
Exercise price per share (in Dollars per share)     $ 10
Shares redeemed 6,119,519    
Ordinary shares outstanding 16,880,481    
Class B Ordinary Shares [Member]      
Initial Public Offering [Line Items]      
Ordinary shares outstanding 5,750,000    
v3.23.3
Private Placement Warrants (Details) - Private Placement [Member] - USD ($)
9 Months Ended
Mar. 14, 2022
Sep. 30, 2023
Private Placement Warrants [Line Items]    
Warrant price per share   $ 1
Aggregate purchase price $ 11,500,000  
Additional paid-in capital   $ 9,251,000
Class A Ordinary Shares [Member]    
Private Placement Warrants [Line Items]    
Warrant price per share   $ 11.5
Private Placement Warrants [Member]    
Private Placement Warrants [Line Items]    
Private placement warrants   14,500,000
Aggregate purchase price   $ 14,500,000
v3.23.3
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Nov. 13, 2023
Oct. 10, 2023
Jul. 12, 2023
Mar. 14, 2022
Mar. 03, 2021
Mar. 03, 2021
Feb. 28, 2022
Jan. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Mar. 09, 2022
Dec. 31, 2021
Related Party Transactions [Line Items]                                
Aggregate purchase price                              
Aggregate ordinary shares (in Shares)       236,900,000                        
Shares subject to forfeiture (in Shares)       750,000                        
Granted shares (in Shares)                       90,000        
Granted share in amount                       $ 662,245        
Granted per shares (in Dollars per share)                       $ 7.36        
Stock compensation expense                       $ 662,245        
Principal amount         $ 250,000 $ 250,000                    
Promissory note                               $ 437,508
Sponsor paid expenses                           $ 150,334    
Outstanding balance                           $ 3,144    
Aggregate deposit                 $ 1,200,000     1,200,000        
Related Party Transaction, Amounts of Transaction                       300,000        
Additional borrowing   $ 300,000                            
Additional deposit     $ 300,000                          
Working capital loans                       $ 2,000,000        
Class B Ordinary Shares [Member]                                
Related Party Transactions [Line Items]                                
Ordinary per share (in Dollars per share)                 $ 0.0001     $ 0.0001   $ 0.0001    
Class A Ordinary Shares [Member]                                
Related Party Transactions [Line Items]                                
Ordinary per share (in Dollars per share)                 0.0001     0.0001   $ 0.0001    
Subsequent Event [Member]                                
Related Party Transactions [Line Items]                                
Additional deposit $ 300,000 $ 300,000                            
Promissory Note – Related Party [Member]                                
Related Party Transactions [Line Items]                                
Additional borrowing amount               $ 250,000                
Total borrowing capacity               $ 500,000                
Working Capital Loans [Member]                                
Related Party Transactions [Line Items]                                
Price per share (in Dollars per share)                 1     $ 1        
Sponsor [Member]                                
Related Party Transactions [Line Items]                                
Monthly fee                       $ 10,000        
Sponsor [Member] | Class A Ordinary Shares [Member]                                
Related Party Transactions [Line Items]                                
Ordinary per share (in Dollars per share)                 $ 12     $ 12        
Founder Shares [Member]                                
Related Party Transactions [Line Items]                                
Shares subject to forfeiture (in Shares)                 90,000     90,000        
Founder Shares [Member] | Sponsor [Member]                                
Related Party Transactions [Line Items]                                
Shares subject to forfeiture (in Shares)             1,437,500                  
Number of shares owned (in Shares)             5,750,000                  
Number Of ohares subject to transferred (in Shares)                             30,000  
Founder Shares [Member] | Sponsor [Member] | Class B Ordinary Shares [Member]                                
Related Party Transactions [Line Items]                                
Aggregate purchase price         $ 25,000                      
Aggregate ordinary shares (in Shares)           7,187,500                    
Founder Shares [Member] | Sponsor [Member] | Class A Ordinary Shares [Member]                                
Related Party Transactions [Line Items]                                
Founder share percentage                       20.00%        
Related Party [Member]                                
Related Party Transactions [Line Items]                                
Due to related party                 $ 1,200,000     $ 1,200,000   $ 3,144    
Related Party [Member] | Sponsor [Member]                                
Related Party Transactions [Line Items]                                
Due to related party                 12,000,000     12,000,000        
Administrative Support Agreement [Member]                                
Related Party Transactions [Line Items]                                
Expenses incurred and paid                 $ 0 $ 30,000   $ 60,000 $ 65,484      
v3.23.3
Commitments and Contingencies (Details)
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Commitments and Contingencies [Line Items]  
Underwriting discount per share (in Dollars per share) | $ / shares $ 0.2
Underwriting cash discount per unit 4,600,000
Underwriting Agreement [Member]  
Commitments and Contingencies [Line Items]  
Underwriting discount per share (in Dollars per share) | $ / shares $ 0.35
Underwriting cash discount per unit 8,050,000
IPO [Member]  
Commitments and Contingencies [Line Items]  
Additional purchase units 3,000,000
v3.23.3
Derivative Warrant Liabilities (Details)
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Derivative Warrant Liabilities [Line Items]  
Warrant price per share | $ / shares $ 11.5
Warrant expiration term 5 years
Business combination, description The Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00” and “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
IPO [Member]  
Derivative Warrant Liabilities [Line Items]  
Warrants issued | shares 26,000,000
Public Warrants [Member]  
Derivative Warrant Liabilities [Line Items]  
Warrants issued | shares 11,500,000
Private Placement Warrants [Member]  
Derivative Warrant Liabilities [Line Items]  
Warrants issued | shares 14,500,000
Class A Ordinary Shares [Member]  
Derivative Warrant Liabilities [Line Items]  
Warrant price per share | $ / shares $ 10
Redemption of warrants, description Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants:   ● in whole and not in part;   ● at a price of $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth in the warrant agreement based on the redemption date and the “redemption fair market value” of Class A Ordinary Shares (as defined below) except as otherwise described in the warrant agreement;   ● if, and only if, the closing price of Class A Ordinary Shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and   ● if the closing price of the Class A Ordinary Shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
Class A Ordinary Shares [Member] | Warrant [Member]  
Derivative Warrant Liabilities [Line Items]  
Warrant price per share | $ / shares $ 11.5
Warrant [Member]  
Derivative Warrant Liabilities [Line Items]  
Redemption of warrants, description Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except as described herein with respect to the Private Placement Warrants):   ● in whole and not in part;   ● at a price of $0.01 per Warrant;   ● upon a minimum of 30 days’ prior written notice of redemption; and   ● if, and only if, the last reported sale price of Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
v3.23.3
Shareholder's Deficit (Details) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Shareholder’s Deficit [Line Items]    
Preferred shares authorized 1,000,000 1,000,000
Preferred shares par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares outstanding
Preferred stock, shares issued
Subject to possible redemption, issued 16,880,481 23,000,000
Subject to possible redemption, outstanding 16,880,481  
Class A Ordinary Shares [Member]    
Shareholder’s Deficit [Line Items]    
Ordinary shares authorized 200,000,000 200,000,000
Ordinary shares par value (in Dollars per share) $ 0.0001 $ 0.0001
Subject to possible redemption, issued 16,880,481 23,000,000
Subject to possible redemption, outstanding 16,880,481 23,000,000
Common Stock, Shares, Issued
Ordinary shares issued
Class B Ordinary Shares [Member]    
Shareholder’s Deficit [Line Items]    
Ordinary shares authorized 20,000,000 20,000,000
Ordinary shares par value (in Dollars per share) $ 0.0001 $ 0.0001
Common Stock, Shares, Issued 5,750,000 5,750,000
Ordinary shares issued 5,750,000 5,750,000
v3.23.3
Fair Value Measurements (Details) - USD ($)
3 Months Ended 7 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2022
Fair Value Measurements [Abstract]              
Fair value of warrant liabilities $ 353,600 $ 1,300,000 $ 4,720,500 $ (780,000) $ (4,720,500) $ (7,060,500) $ (7,060,500)
v3.23.3
Fair Value Measurements (Details) - Schedule of Company’s Assets and Liabilities are Measured at Fair Value on a Recurring Basis - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Assets    
Marketable securities held in Trust Account $ 183,950,121 $ 240,311,986
Total assets 183,950,121 240,311,986
Liabilities    
Total liabilities 1,560,000 2,340,000
Public Warrants [Member]    
Liabilities    
Total Warrants 690,000 1,035,000
Private Placement Warrants [Member]    
Liabilities    
Total Warrants 870,000 1,305,000
Level 1 [Member]    
Assets    
Marketable securities held in Trust Account 183,950,121 240,311,986
Total assets 183,950,121 240,311,986
Liabilities    
Total liabilities 690,000 1,035,000
Level 1 [Member] | Public Warrants [Member]    
Liabilities    
Total Warrants 690,000 1,035,000
Level 1 [Member] | Private Placement Warrants [Member]    
Liabilities    
Total Warrants
Level 2 [Member]    
Assets    
Marketable securities held in Trust Account
Total assets
Liabilities    
Total liabilities 870,000 1,305,000
Level 2 [Member] | Public Warrants [Member]    
Liabilities    
Total Warrants
Level 2 [Member] | Private Placement Warrants [Member]    
Liabilities    
Total Warrants 870,000 1,305,000
Level 3 [Member]    
Assets    
Marketable securities held in Trust Account
Total assets
Liabilities    
Total liabilities
Level 3 [Member] | Public Warrants [Member]    
Liabilities    
Total Warrants
Level 3 [Member] | Private Placement Warrants [Member]    
Liabilities    
Total Warrants
v3.23.3
Fair Value Measurements (Details) - Schedule of Public and Private Warrants Were Transferred Out of Level 3 into Level 1 and Level 2 - USD ($)
3 Months Ended 7 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2022
Schedule of Public and Private Warrants were Transferred Out of Level 3 into Level 1 and Level 2 [Line Items]              
Level 3 warrant liabilities at January 1, 2022        
Addition at March 14, 2022           $ 9,400,500  
Change in fair value of warrant liabilities $ 353,600 $ 1,300,000 $ 4,720,500 $ (780,000) $ (4,720,500) (7,060,500) (7,060,500)
Level 3 warrant liabilities at December 31, 2022          
Transfers from level 3 to level 2 instruments [Member]              
Schedule of Public and Private Warrants were Transferred Out of Level 3 into Level 1 and Level 2 [Line Items]              
Transfers from level instruments           (1,305,000) (1,305,000)
Transfers from level 3 to level 1 instruments [Member]              
Schedule of Public and Private Warrants were Transferred Out of Level 3 into Level 1 and Level 2 [Line Items]              
Transfers from level instruments           $ (1,035,000) $ (1,035,000)
v3.23.3
Fair Value Measurements (Details) - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Inputs for the Public Warrants and Private Placement Warrants
Mar. 14, 2022
$ / shares
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Inputs for the Public Warrants and Private Placement Warrants [Abstract]  
Exercise Price $ 11.5
Underlying share price $ 9.82
Volatility 5.40%
Term to Business Combination (years) 6 years 18 days
Risk-free rate 2.13%
v3.23.3
Fair Value Measurements (Details) - Schedule of Change in Fair Value of the Derivative Warrant Liabilities - USD ($)
3 Months Ended 7 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2022
Schedule of Change in Fair Value of the Derivative Warrant Liabilities [Line Items]              
Fair value at beginning       $ 2,340,000  
Fair value at March 14, 2022     $ 9,400,500        
Change in fair value $ 353,600 $ 1,300,000 4,720,500 (780,000) (4,720,500) $ (7,060,500) (7,060,500)
Fair value as of ending 1,560,000 4,680,000 4,680,000 1,560,000 4,680,000 2,340,000 2,340,000
Private Warrant [Member]              
Schedule of Change in Fair Value of the Derivative Warrant Liabilities [Line Items]              
Fair value at beginning       1,305,000  
Fair value at March 14, 2022     4,151,500        
Change in fair value     2,081,500 (435,000)      
Fair value as of ending 870,000 2,070,000 2,070,000 870,000 2,070,000 1,305,000 1,305,000
Public Warrants [Member]              
Schedule of Change in Fair Value of the Derivative Warrant Liabilities [Line Items]              
Fair value at beginning       1,035,000  
Fair value at March 14, 2022     5,249,000        
Change in fair value     2,639,000 (34,500)      
Fair value as of ending $ 690,000 $ 2,610,000 $ 2,610,000 $ 690,000 $ 2,610,000 $ 1,035,000 $ 1,035,000

Patria Latin American Op... (NASDAQ:PLAOU)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Patria Latin American Op... Charts.
Patria Latin American Op... (NASDAQ:PLAOU)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Patria Latin American Op... Charts.